菜单 Close 公司首页 公司介绍 公司动态 证书荣誉 联系方式 在线留言
您当前的位置: 网站首页 > 公司动态 >NIBSC代理产品

NIBSC代理产品

发表时间:2025-07-10
货号 品名 规格
WY-NIBSC-SS-319/20 FITC CD4 Positive Control Cells 1EA
WY-NIBSC-00/410 MAPREC assay of poliovirus type 1 (Sabin).100% 480-A, 525-C DNA(1st International Reference Preparation) 1EA
WY-NIBSC-00/416 Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation) 1EA
WY-NIBSC-00/418 MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard) 1EA
WY-NIBSC-00/422 High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation) 1EA
WY-NIBSC-00/440 Influenza Antiserum A/Singapore/1/57 (H2) 1EA
WY-NIBSC-00/442 Influenza anti B/Yamanashi/166/98 Serum 1EA
WY-NIBSC-00/498 Diphtheria Antitoxin Human IgG 1EA
WY-NIBSC-00/500 Botulinum Type A-E Antitoxin, Human Serum 1EA
WY-NIBSC-00/542 Influenza anti- A/Chick/Scotland/59 (H5N1) Serum 1EA
WY-NIBSC-00/546 Influenza Antigen B/Johannesburg/5/99 1EA
WY-NIBSC-00/548 Influenza Antigen A/Singapore/1/57 (H2N2) 1EA
WY-NIBSC-00/552 Influenza Antigen A/Duck/Singapore-Q/F119-3/97 (H5N3) 1EA
WY-NIBSC-00/556 Influenza anti-B/Johannesburg/5/99/ Serum 1EA
WY-NIBSC-00/572 Interferon Beta (Human, rDNA, Glycosylated) (3rd International standard) 1EA
WY-NIBSC-00/574 Interferon Beta SER17 Mutein (Human, rDNA derived) 1EA
WY-NIBSC-00/576 Interferon Beta (Human, Fibroblast-derived, Glycosylated) 1EA
WY-NIBSC-007SP Human Anti-Pneumococcal capsule Reference Serum (1st International Standard) 1EA
WY-NIBSC-01/412 Anti-Meningococcal Immunotype L3,7,9 Monoclonal Antibody 1EA
WY-NIBSC-01/420 Interleukin-17 (Human rDNA derived)(WHO Reference Reagent) 1EA
WY-NIBSC-01/450 Influenza anti B/Guangdong/120/2000 Serum 1EA
WY-NIBSC-01/452 Influenza anti A/Panama/2007/99 (H3N2) HA serum 1EA
WY-NIBSC-01/506 Botulinum type F antitoxin, equine 1EA
WY-NIBSC-01/508 Botulinum type C antitoxin, equine 1EA
WY-NIBSC-01/510 Botulinum Antitoxin Equine Type D 1EA
WY-NIBSC-01/512 Botulinum type G antitoxin, equine 1EA
WY-NIBSC-01/514 Anti-Meningococcal Serosubtype P1.7 Monoclonal Antibody 1EA
WY-NIBSC-01/538 Anti-Meningococcal Serosubtype P1.16 mAb 1EA
WY-NIBSC-01/546 Influenza Antigen B/Guangdong/120/2000 1EA
WY-NIBSC-01/600 Anti-Toxoplasma IgG, Human(International Standard) 1EA
WY-NIBSC-01/602 Anti-Parvovirus B19, plasma, human(2nd International Standard) 1EA
WY-NIBSC-01/612 Influenza Virus infectious B/Hawaii/10/01 1EA
WY-NIBSC-01/614 Influenza Antigen A/New Caledonia/20/99 1EA
WY-NIBSC-02/102 Influenza anti A/Panama/2007/99 Serum 1EA
WY-NIBSC-02/144 Anti-Meningococcal Serosubtype P1.15 mAb 1EA
WY-NIBSC-02/148 Anti-Meningococcal Serosubtype P1.4 mAb 1EA
WY-NIBSC-02/178 Anti-Meningococcal Serosubtype P1.2 mAb 1EA
WY-NIBSC-02/180 Anti-Meningococcal Serotype P2.2a mAb 1EA
WY-NIBSC-02/182 Anti-Japanese Encephalitis Virus Plasma, Human 1EA
WY-NIBSC-02/184 Anti-Japanese Encephalitis (Anti-JE) Virus Negative Control Plasma, Human 1EA
WY-NIBSC-02/210 HIV (antibody), 1st International Reference Panel 1EA
WY-NIBSC-02/226 IVIG negative control for use with IVIG + anti-D(WHO Reference Reagent) 1EA
WY-NIBSC-02/228 IVIG + anti-D for use with negative control IVIG(WHO Reference Reagent) 1EA
WY-NIBSC-02/230 Biotinylated Brad-5 (Bio-Brad-5) 1EA
WY-NIBSC-02/232 Tetanus Toxoid (Non-Adsorbed) 1EA
WY-NIBSC-02/294 Influenza Antiserum A/chick/Italy/1347/99 (H7N1) 1EA
WY-NIBSC-02/308 Anti-Meningococcal Serotype P3.4 mAb 1EA
WY-NIBSC-02/310 Anti-Meningococcal Serotype P3.15 mAb 1EA
WY-NIBSC-02/318 Botulinum Antitoxin Equine Type E 1EA
WY-NIBSC-02/320 Anti-Meningococcal Serosubtype P1.3 mAb 1EA
WY-NIBSC-02/336 Influenza Antigen A/New Caledonia/20/99 1EA
WY-NIBSC-02/338 Influenza anti A/Panama/2007/99 Serum 1EA
WY-NIBSC-02/342 Protein C Plasma, Human(2nd International Standard) 1EA
WY-NIBSC-03/104 HTLV-1 (antibody) Monitor Sample 1EA
WY-NIBSC-03/110 Influenza anti B/Shangdong/9/97 Serum 1EA
WY-NIBSC-03/114 Anti-Meningococcal Serosubtype P1.1 mAb 1EA
WY-NIBSC-03/124 Thrombopoietin ( Human rDNA derived) 1EA
WY-NIBSC-03/142 Anti-Meningococcal Serosubtype P1.14 mAb 1EA
WY-NIBSC-03/148 Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st WHO Reference Reagent) 1EA
WY-NIBSC-03/150 Keratinocyte Growth Factor (KGF,FGF-7)(1st WHO Reference Reagent) 1EA
WY-NIBSC-03/152 Anti-HPA-1a (International Standard) 1EA
WY-NIBSC-03/164 Anti-B minimum potency reference preparation(International Standard) 1EA
WY-NIBSC-03/178 Vitamin B12, Serum Folate and holoTC (International standard) 1EA
WY-NIBSC-03/182 Anti-Meningococcal Serotype P3.21 mAb 1EA
WY-NIBSC-03/188 Anti-A minimum potency reference preparation(International Standard) 1EA
WY-NIBSC-03/190 Anti-HPA-3a(minimum potency)(WHO Reference Reagent) 1EA
WY-NIBSC-03/192 Thyroid-Stimulating Hormone, Recombinant, Human, for Bioassay (1st International standard) 1EA
WY-NIBSC-03/200 Interleukin - 18 (Human rDNA derived)(WHO Reference Reagent) 1EA
WY-NIBSC-03/210 Anti-Meningiococcal Serosubtype P1.6 mAb 1EA
WY-NIBSC-03/212 Influenza anti A/Wyoming/03/03 Serum 1EA
WY-NIBSC-03/220 Influenza Antigen A/Wyoming/03/03 1EA
WY-NIBSC-03/224 Anti-Meningococcal Serosubtype P1.10 mAb 1EA
WY-NIBSC-03/226 Anti-Meningococcal Serosubtype P1.5 mAb 1EA
WY-NIBSC-03/228 Protein S, Plasma, Human(2nd International Standard) 1EA
WY-NIBSC-03/236 Anti-Meningococcal Serosubtype P1.13 mAb 1EA
WY-NIBSC-03/242 Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum 1EA
WY-NIBSC-03/244 Influenza Antiserum A/chick/Germany/N/49 1EA
WY-NIBSC-03/258 Influenza Antigen A/New Caledonia/20/99 (IVR-116) 1EA
WY-NIBSC-03/262 Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel) 1EA
WY-NIBSC-04/160 Influenza Virus infectious NYMC X-147 1EA
WY-NIBSC-04/166 TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st WHO Reference Reagent) 1EA
WY-NIBSC-04/170 Influenza Virus infectious A/Wellington/1/2004 1EA
WY-NIBSC-04/172 Influenza Virus infectious IVR-139 1EA
WY-NIBSC-04/176 Plasmodium falciparum DNA for NAT Assays(1st International Standard) 1EA
WY-NIBSC-04/198 Anti-Meningococcal Serotype P3.1 mAb 1EA
WY-NIBSC-04/202 Influenza Antigen B/ Jiangsu/10/2003 1EA
WY-NIBSC-04/224 Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004 1EA
WY-NIBSC-04/228 Influenza anti B/ Neuraminidase Serum 1EA
WY-NIBSC-04/242 Influenza anti B/Jiangsu/10/2003 HA Serum 1EA
WY-NIBSC-04/246 Anti-Meningococcal Serogroup W-135 mAb 1EA
WY-NIBSC-04/248 Anti-Meningococcal Serosubtype P1.19 mAb 1EA
WY-NIBSC-04/252 Protein C Concentrate, Human(1st International Standard) 1EA
WY-NIBSC-04/260 Influenza anti A/New Caledonia/20/99 HA Serum 1EA
WY-NIBSC-04/262 Influenza anti A/New York/55/2004 HA Serum 1EA
WY-NIBSC-04/264 Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157) 1EA
WY-NIBSC-05/102 Influenza Virus infectious NYMC BX-7 1EA
WY-NIBSC-05/106 Anti-HPA-1a minimum potency reagent(2nd WHO Reference reagent) 1EA
WY-NIBSC-05/112 Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard) 1EA
WY-NIBSC-05/130 Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005) 1EA
WY-NIBSC-05/134 Anti-human papillomavirus type 16 serum (1st International Standard) 1EA
WY-NIBSC-05/162 Alpha-1-Antitrypsin, plasma derived(1st International standard) 1EA
WY-NIBSC-05/190 Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody 1EA
WY-NIBSC-05/192 Anti Meningococcal Serotype P2.2b Monoclonal Antibody 1EA
WY-NIBSC-05/234 Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142) 1EA
WY-NIBSC-05/236 Influenza anti A/Wisconsin/67/2005 Serum 1EA
WY-NIBSC-05/252 Influenza anti B Neuraminidase Serum 1EA
WY-NIBSC-06/108 Influenza Virus infectious IVR-116 1EA
WY-NIBSC-06/124 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 2 (1st International Standard) 1EA
WY-NIBSC-06/128 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 3 (1st International Standard) 1EA
WY-NIBSC-06/140 Pertussis Antiserum(human)1st IS-WHO international Standard 1EA
WY-NIBSC-06/142 Pertussis Antiserum (Human) 1st WHO Reference Reagent 1EA
WY-NIBSC-06/164 Influenza Virus infectious 1 VR-142 1EA
WY-NIBSC-06/166 Antithrombin Concentrate, Human (3rd International Standard) 1EA
WY-NIBSC-06/170 Influenza Antigen A/New Caledonia/20/99 1EA
WY-NIBSC-06/192 Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466) 1EA
WY-NIBSC-06/202 Human Papillomavirus (HPV) Type 16 DNA (1st International Standard) 1EA
WY-NIBSC-06/206 Human Papillomavirus (HPV) Type 18 DNA (1st International Standard) 1EA
WY-NIBSC-06/242 Influenza Virus Infectious NYMC X-161B (A/Wisconsin/67/2005 HGR) 1EA
WY-NIBSC-0688 SARS CoV-1 spike S1 protein 1EA
WY-NIBSC-07/102 Influenza Antigen A/Solomon Islands/3/2006 (H1N1)(IVR-145) 1EA
WY-NIBSC-07/104 Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum 1EA
WY-NIBSC-07/112 Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 1EA
WY-NIBSC-07/144 Influenza Virus infectious IVR-145 1EA
WY-NIBSC-07/146 Influenza anti A/HongKong/1073/99 like (H9) HA Serum (sheep) 1EA
WY-NIBSC-07/148 Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum 1EA
WY-NIBSC-07/150 Human Plasma Anti-Influenza H5N1 (1st International Standard) 1EA
WY-NIBSC-07/164 Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard) 1EA
WY-NIBSC-07/184 Influenza anti B/Malaysia/2506/2004-HA Serum 1EA
WY-NIBSC-07/202 Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent) 1EA
WY-NIBSC-07/216 Diphtheria Toxoid (Adsorbed) (4th International Standard) 1EA
WY-NIBSC-07/222 RhD/SRY Plasma DNA sensitivity standard (1st WHO Reference Reagent) 1EA
WY-NIBSC-07/228 Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard 1EA
WY-NIBSC-07/270 BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent) 1EA
WY-NIBSC-07/272 BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent) 1EA
WY-NIBSC-07/274 BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent) 1EA
WY-NIBSC-07/278 Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475) 1EA
WY-NIBSC-07/286 Monitor sample for HBsAg 0.05IU/ml 1EA
WY-NIBSC-07/288 Hepatitis B Surface Antigen (HBsAg) British Working Standard 0.2 IU/ml 1EA
WY-NIBSC-07/290 Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6 1EA
WY-NIBSC-07/296 Influenza Virus (A/Christchurch/1/2003, H1N1) for Nucleic Acid Amplification Techniques 1EA
WY-NIBSC-07/298 Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques 1EA
WY-NIBSC-07/300 Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques 1EA
WY-NIBSC-07/306 Anti-A and anti-B in IVIG: Positive control for haemagglutination tests (WHO Reference Reagent) 1EA
WY-NIBSC-07/316 Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.) 1EA
WY-NIBSC-07/318 Meningococcal Group C Polysaccharide 1EA
WY-NIBSC-07/328 Unfractionated Heparin (6th I.S.) 1EA
WY-NIBSC-07/336 Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60 1EA
WY-NIBSC-07/338 Influenza antiserum A/Anhui/1/05 (H5) 1EA
WY-NIBSC-07/348 Influenza Virus infectious NYMC X-171B 1EA
WY-NIBSC-07/350 Blood Coagulation Factor VIII Concentrate (8th I.S.) 1EA
WY-NIBSC-07/358 Influenza Virus infectious NIB-50 1EA
WY-NIBSC-07/362 Influenza Virus infectious IVR-149 1EA
WY-NIBSC-07/B498 QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1 1EA
WY-NIBSC-08/100 Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1) 1EA
WY-NIBSC-08/108 Influenza Virus Infectious NIBRG-91 (H9N2) 1EA
WY-NIBSC-08/126 Influenza Anti N1 Neuraminidase Serum SH485 1EA
WY-NIBSC-08/138 Influenza Virus Infectious B/Florida/4/2006 1EA
WY-NIBSC-08/140 Influenza Antigen B/Florida/4/2006 1EA
WY-NIBSC-08/142 Influenza antiserum A/Anhui/1/05 (H5) 1EA
WY-NIBSC-08/154 Influenza Virus Infectious NIBRG-12 (H5N1) 1EA
WY-NIBSC-08/156 Influenza Virus Infectious NIBRG-23 30060 VE3 (H5N1) 1EA
WY-NIBSC-08/158 Fragile X Syndrome gDNA (1st International Genetic Reference Panel) 1EA
WY-NIBSC-08/160 Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel) 1EA
WY-NIBSC-08/178 Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques 1EA
WY-NIBSC-08/184 Influenza Antigen B/Malaysia/2506/2004 1EA
WY-NIBSC-08/202 Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1) 1EA
WY-NIBSC-08/204 Thyroid Stimulating Antibody (2nd I.S.) 1EA
WY-NIBSC-08/208 Influenza Antigen A/HongKong/1073/99 (H9N2) 1EA
WY-NIBSC-08/210 Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86) 1EA
WY-NIBSC-08/216 Influenza Antigen A/Cambodia/RO405050/2007 (H5N1) 1EA
WY-NIBSC-08/218 Tetanus Toxoid Adsorbed (4th International Standard) 1EA
WY-NIBSC-08/228 Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91 1EA
WY-NIBSC-08/230 Streptodornase (2nd International Standard) 1EA
WY-NIBSC-08/246 Influenza anti A/Brisbane/10/2007- like HA serum 1EA
WY-NIBSC-08/248 Influenza Virus Infectious NIBRG-107 VE2 30480 1EA
WY-NIBSC-08/252 Influenza Virus Infectious NIBRG-109 VE2 30490 1EA
WY-NIBSC-08/256 C1- Inhibitor, Concentrate (1st International Standard) 1EA
WY-NIBSC-08/258 Antithrombin, Plasma (3rd International Standard) 1EA
WY-NIBSC-08/262 C1 Inhibitor (Plasma)(1st International Standard) 1EA
WY-NIBSC-08/266 Sex Hormone Binding Globulin.(2nd International Standard) 1EA
WY-NIBSC-08/268 Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107 1EA
WY-NIBSC-08/278 Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C)) 1EA
WY-NIBSC-08/298 Influenza Virus Infectious B/Brisbane/33/2008 30720 E5 1EA
WY-NIBSC-08/300 Influenza Virus Infectious IVR-148 1EA
WY-NIBSC-08/304 Influenza virus infectious NYMC X-175C 1EA
WY-NIBSC-08/322 Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing 1EA
WY-NIBSC-08/324 Human Rhinovirus Genogroup A Working Reagent for Nucleic Acid Amplification Testing 1EA
WY-NIBSC-08/356 Influenza antiserum A/Japan/305/57 (H2) 1EA
WY-NIBSC-08/362 Influenza Antigen A/New York/107/2003 (H7N2)NIBRG-109 1EA
WY-NIBSC-09/100 Influenza anti A/mallard/England/727/2006 (N3) NA serum (NIBRG-107) (Sheep SH503) 1EA
WY-NIBSC-09/110 Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard) 1EA
WY-NIBSC-09/130 Influenza Virus Infectious NIBRG-122 1EA
WY-NIBSC-09/136 Granulocyte Colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard) 1EA
WY-NIBSC-09/138 Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR (1st I.S.) 1EA
WY-NIBSC-09/140 Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel) 1EA
WY-NIBSC-09/148 Influenza anti A/New York/107/2003 (H7) HA serum (Sheep SH504 and SH505) 1EA
WY-NIBSC-09/162 Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard) 1EA
WY-NIBSC-09/170 Anti-Meningococcal factor H binding protein variant 1 (JAR4) monoclonal antibody 1EA
WY-NIBSC-09/172 Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard 2010) 1EA
WY-NIBSC-09/174 Influenza Antigen A/California/7/09 (H1N1)v (NYMCX-179A)(Cell Derived) 1EA
WY-NIBSC-09/182 VWF Factor Concentrate (2nd International Standard) 1EA
WY-NIBSC-09/184 Influenza Antigen A/Vietnam/1194/2004 (H5N1) NIBRG-14 1EA
WY-NIBSC-09/186 Chagas (anti-Trypanosoma cruzi II) antibody in human plasma(1st International Standard) 1EA
WY-NIBSC-09/188 Chagas (anti-Trypanosoma cruzi I) antibody in Human Plasma (1st International Standard) 1EA
WY-NIBSC-09/196 Influenza Antigen A/California/7/09 (H1N1)v (NIBRG-121xp) (Egg Derived) 1EA
WY-NIBSC-09/222 Human anti-Haemophilus influenzae b reference serum 1EA
WY-NIBSC-09/234 Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-? 3) (1st International Standard) 1EA
WY-NIBSC-09/236 Influenza Virus Infectious IVR-153 1EA
WY-NIBSC-09/242 Fibrinogen Concentrate (B)(2nd International Standard) 1EA
WY-NIBSC-09/260 Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard) 1EA
WY-NIBSC-09/264 Fibrinogen Plasma (D)(3rd International Standard) 1EA
WY-NIBSC-09/266 LIAL CELL-DERIVED NEUROTROPHIC FACTOR (GDNF), human, rDNA-derived 1EA
WY-NIBSC-09/268 Influenza Virus Infectious NIBRG-121xp 1EA
WY-NIBSC-09/272 Placental growth factor Ala 21 - Arg 149, human, rDNA-derived (PlGF, PlGF-1) 1EA
WY-NIBSC-09/274 Influenza Virus Infectious NYMC X-185 1EA
WY-NIBSC-09/280 Influenza Virus Infectious NIB-64 1EA
WY-NIBSC-09/284 Anti-Human Neutrophil Antibody 1a WHO Reference Reagent 1EA
WY-NIBSC-09/296 Pro-Insulin, human (1st International Standard) 1EA
WY-NIBSC-09/304 Influenza Virus Infectious IVR-155 1EA
WY-NIBSC-09/308 Influenza Serology Antigen Reagent X-179A (H1N1pdm) for HI Assay 1EA
WY-NIBSC-09/310 Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183) 1EA
WY-NIBSC-10/104 Reteplase Reference Material 1EA
WY-NIBSC-10/120 Influenza Anti A/Brisbane/59/2007 (IVR 148)(H1N1) HA serum 1EA
WY-NIBSC-10/128 Diphtheria Polyclonal Antibody 1EA
WY-NIBSC-10/130 Diphtheria Monoclonal Antibody 1EA
WY-NIBSC-10/132 Tetanus Polyclonal Antibody 1EA
WY-NIBSC-10/134 Tetanus Monoclonal Antibody 1EA
WY-NIBSC-10/140 Anti-human papillomavirus[HPV] 18 serum (1st International Standard) 1EA
WY-NIBSC-10/164 Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain] 1EA
WY-NIBSC-10/168 Oral Poliovaccine Sabin Type 3 reference 1EA
WY-NIBSC-10/176 Interleukin-29 (Interferon Lambda, Human, rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-10/178 Endotoxin (3rd International Standard) 1EA
WY-NIBSC-10/198 Anti-malaria (Plasmodium falciparum) human serum(1st WHO Reference Reagent) 1EA
WY-NIBSC-10/202 Influenza antibody (Human) to A/California/7/2009 'like' (H1N1v) virus (2nd International Standard) 1EA
WY-NIBSC-10/214 Influenza Anti N2 Neuraminidase Serum SH395 & SH396 1EA
WY-NIBSC-10/218 Influenza Anti A/California/7/2009 (N1) NA Serum 1EA
WY-NIBSC-10/226 Influenza Virus Infectious IVR-158 1EA
WY-NIBSC-10/232 Blood Group Genotyping Reference Reagent RBC1 (OR1R2)(WHO Reference Reagent) 1EA
WY-NIBSC-10/234 Blood Group Genotyping Reference Reagent RBC12 (ODpsi)(WHO Reference Reagent) 1EA
WY-NIBSC-10/236 Blood Group Genotyping Reference Reagent RBC4 (AR1R1)(WHO Reference Reagent) 1EA
WY-NIBSC-10/238 Blood Group Genotyping Reference Reagent RBC5 (Brr)(WHO Reference Reagent) 1EA
WY-NIBSC-10/242 Toxoplasma gondii DNA Nucleic Acid Amplification Techniques(1st International Standard) 1EA
WY-NIBSC-10/252 Factor VII Concentrate (2nd International Standard) 1EA
WY-NIBSC-10/258 Influenza Antigen A/California/7/2009-like(NIB-74) 1EA
WY-NIBSC-10/262 Diphtheria Antitoxin Human IgG(1st International Standard) 1EA
WY-NIBSC-10/272 BCG vaccine of Moreau-RJ sub-strain(1st WHO Reference Reagent) 1EA
WY-NIBSC-10/286 Follicle Stimulating Hormone, Luteinizing Hormone human, urinary for bioassay(5th International Standard) 1EA
WY-NIBSC-100976 pCAGGS-SARS-CoV-2-Spike 1EA
WY-NIBSC-100980 SARS-CoV-2 infectious virus (BetaCoV/Australia/VIC01/2020 1EA
WY-NIBSC-100985 pCAGGS_SARS-CoV-2_Spike D614G 1EA
WY-NIBSC-100986 pCAGGS-SARS-CoV-2-Spike Bristol Deletion 1EA
WY-NIBSC-100987 Inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020 1EA
WY-NIBSC-100988 Nucleic acid extracts from inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020 1EA
WY-NIBSC-100989 pCRII-SARS-CoV-2 (5'UTR-NSP2) 1EA
WY-NIBSC-100991 pCRII-SARS-CoV-2 (NSP4-NSP8) 1EA
WY-NIBSC-100992 pCRII-SARS-CoV-2 (NSP4-NSP8) 1EA
WY-NIBSC-100994 pCRII-SARS-CoV-2 (NSP15-NSP16) 1EA
WY-NIBSC-100996 pCRII-SARS-CoV-2 (ORF3a-ORF6) 1EA
WY-NIBSC-100998 SARS-CoV-2 infectious virus (CVR-GLA 1) 1EA
WY-NIBSC-100999 SARS-CoV-2 infectious virus(CVR-GLA 2) 1EA
WY-NIBSC-101000 SARS-CoV-2 infectious virus(CVR-GLA 3) 1EA
WY-NIBSC-101001 VeroE6-ACE2 1EA
WY-NIBSC-101003 VeroE6-ACE2-TMPRSS2 1EA
WY-NIBSC-101004 A549-ACE2-TMPRSS2 1EA
WY-NIBSC-101005 A549-ACE2 Clone8 1EA
WY-NIBSC-101006 A549-ACE-2 Clone 8-TMPRSS2 1EA
WY-NIBSC-101007 SARS-CoV-2 Trimeric Spike 50ug (1mg/ml in PBS) Sterile #28.05.2020 1EA
WY-NIBSC-101008 HEK293T-ACE2-TMPRSS2 1EA
WY-NIBSC-101009 Anti-SARS-CoV-2 Nucleocaspid protein (CR3009) 1EA
WY-NIBSC-101010 Anti-SARS-CoV-2 Nucleocapsid protein (CR3018) 1EA
WY-NIBSC-101011 Anti-SARS-CoV-2 Nucleocapsid protein (CR3009 Human/Mouse HC) 1EA
WY-NIBSC-101019 VOC-202012/01 (B.1.1.7 lineage) lot 26012021 1EA
WY-NIBSC-101022 SARS-CoV-2 VOC202012/02 (B.1.351 lineage) passage 4 1EA
WY-NIBSC-101023 pl.18SARS-CoV-2-Spike (B.1.1.7) 1ug (100ng/ul) lot #24032021 1EA
WY-NIBSC-101024 pl. 18SARS-CoV-2-Spike (B.1.351) 1ug (100ng/ul) lot #24032021 1EA
WY-NIBSC-101025 4% formaldehyde inactivated SARS CoV-2 BetaCoV/Australia/VIC01/2020 from VeroE6/TMPRSS2 1EA
WY-NIBSC-101027 Acid/heat inactivated SARS-CoV-2 (B.1.1.7) lot 17022021 1EA
WY-NIBSC-101029 SARS-CoV-2 Alpha (B.1.1.7) Purified RNA extracts lot 20052021 1EA
WY-NIBSC-101030 SARS-CoV-2 VOC-202104/02 (B.1.617.2 lineage) 1EA
WY-NIBSC-101031 SARS-CoV-2 VOC-21FEB02 (B.1.1.7 lineage + E484K) 1EA
WY-NIBSC-101032 SARS-CoV-2 Kappa (B.1.617.1 lineage 1EA
WY-NIBSC-101033 SARS-CoV-2 Delta (AY.1 sub-lineage) 1EA
WY-NIBSC-101034 SARS-CoV-2 Mu (B.1.621 lineage) 1EA
WY-NIBSC-101035 Acid/Heat Inactivated SARS-CoV-2 Beta (B.1.351 lineage) 1EA
WY-NIBSC-101036 Acid/Heat Inactivated SARS-CoV-2 Delta (B.1.617.2 lineage 1EA
WY-NIBSC-101038 0.01% Formaldehyde Inactivated SARS-CoV-2 Beta (B.1.351 lineage) 1EA
WY-NIBSC-101039 0.01% Formaldehyde Inactivated SARS-CoV-2 Delta (B.1.617.2 lineage) 1EA
WY-NIBSC-101042 SARS-CoV-2 Nucleocapsid protein (His tagged) 1EA
WY-NIBSC-101043 SARS-CoV-2 Nucleocapsid protein 203/204:RG>KR (His tagged) 1EA
WY-NIBSC-101047 Inactivated (Acetic Acid + Heat)SARS-CoV-2 Omicron (BA.1 sublineage) 1EA
WY-NIBSC-101054 SARS-CoV-2 Omicron BA.1.1 sublineage lot 28032022 1EA
WY-NIBSC-101055 SARS-CoV-2 Omicron (BA.2) 1EA
WY-NIBSC-101062 HEK293T-ACE2-30F-PLP2 1EA
WY-NIBSC-1050 IPV ELISA MAbs Type 1, 2 and 3 (Type 2; No: 1050) 1EA
WY-NIBSC-11/108 Influenza Virus infectious NYMC X-187 1EA
WY-NIBSC-11/126 Factors II and X Concentrate (4th International standard) 1EA
WY-NIBSC-11/134 Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived) 1EA
WY-NIBSC-11/170 Erythropoietin, recombinant, for Bioassay (3rd International Standard) 1EA
WY-NIBSC-11/176 (3rd International Standard) Low Molecular Weight Heparin 1EA
WY-NIBSC-11/184 High Molecular Weight Urokinase(2nd International Standard) 1EA
WY-NIBSC-11/206 Influenza anti-A/Perth/16/2009 HA Serum 1EA
WY-NIBSC-11/210 Anti-human CD4 FITC conjugated 0.5ml 1EA
WY-NIBSC-11/214 Blood Group Genotyping Reference Reagents Panel (WHO Reference Reagent) 1EA
WY-NIBSC-11/216 Chagas Antibody Reference Panel ( 1st International Standard) 1EA
WY-NIBSC-11/222 Influenza Virus Infectious NIB-79 1EA
WY-NIBSC-11/232 Influenza Virus Infectious B/Texas/6/2011 1EA
WY-NIBSC-11/234 Immunoglobulin E(IgE) human serum (3rd International Standard) 1EA
WY-NIBSC-11/242 Viral Multiplex Reference 1EA
WY-NIBSC-11/244 Influenza Virus Infectious NYMC BX-49 1EA
WY-NIBSC-11/B608 QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1 1EA
WY-NIBSC-12/100 Influenza Virus Infectious NYMC X-217 1EA
WY-NIBSC-12/104 International Standard for IPV 12/104 (3rd International Standard) 1EA
WY-NIBSC-12/106 Influenza Antigen B/Hubei-Wujiagang/158/2009 (NYMCBX-39) 1EA
WY-NIBSC-12/110 Influenza Antigen B/Wisconsin/1/2010 (cell derived) 1EA
WY-NIBSC-12/112 Influenza Antigen A/Victoria/210/2009 (H3N2) (NYMCX-187) 1EA
WY-NIBSC-12/114 Influenza Antigen A/Victoria/361/2011 (H3N2) (IVR-165) 1EA
WY-NIBSC-12/116 Influenza anti-A/Victoria/361/2011-like HA serum 1EA
WY-NIBSC-12/118 Influenza anti-B/Wisconsin/1/2010-like HA serum 1EA
WY-NIBSC-12/122 Influenza virus infectious A/turkey/Italy/3889/1999 (H7N1) 1EA
WY-NIBSC-12/154 Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard) 1EA
WY-NIBSC-12/176 Methylated Human Serum Albumin (mHSA) 1EA
WY-NIBSC-12/188 Pegylated Granulocyte Colony Stimulating Factor (Human, rDNA derived) (1st International Standard) 1EA
WY-NIBSC-12/198 Influenza virus infectious B/Wisconsin/1/2010 34490 E5 1EA
WY-NIBSC-12/202 Influenza virus infectious NYMC BX-39 1EA
WY-NIBSC-12/204 Influenza Virus infectious IVR-165 1EA
WY-NIBSC-12/208 Parvovirus B19 (3rd International Standard) 1EA
WY-NIBSC-12/224 HIV-1 NAT subtypes (Main)(2nd International Reference Panel Preparation) 1EA
WY-NIBSC-12/226 HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard) 1EA
WY-NIBSC-12/244 Vi polysaccharide of C freundii WHO 1st International Standard 1EA
WY-NIBSC-12/250 Influenza anti A/Mallard/England 727/2006 (H2) HA Serum 1EA
WY-NIBSC-12/252 ADAMTS 13 Plasma (1st International Standard) 1EA
WY-NIBSC-12/282 Diphtheria Toxin 1Lf/ml 1EA
WY-NIBSC-12/284 Anti-meningococcal serogroup Y monoclonal antibody 1EA
WY-NIBSC-12/290 Influenza Virus Infectious B/Brisbane/36/2012 1EA
WY-NIBSC-12/294 Influenza Virus Infectious NYMC BX-51C 1EA
WY-NIBSC-12/B612 QCRRUBIgMQC1-Anti-Rubella IgM Quality Control Serum: Sample 1 1EA
WY-NIBSC-13/100 Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard) 1EA
WY-NIBSC-13/106 Influenza Antigen B/Massachusetts/02/2012 1EA
WY-NIBSC-13/108 Anti-Meningococcal serogroup B monoclonal antibody 1EA
WY-NIBSC-13/112 Influenza Antigen A/Texas/50/2012 (NYMC X-223) 1EA
WY-NIBSC-13/116 Influenza Antigen A/Texas/50/2012 (NYMC X-223A) 1EA
WY-NIBSC-13/122 Erythropoietin Antibody Reference Panel Negative Control Antibody (1st WHO Reference Panel) 1EA
WY-NIBSC-13/126 Influenza anti-B/Brisbane/60/2008-like HA serum 1EA
WY-NIBSC-13/128 Influenza Virus Infectious NIBRG-269 1EA
WY-NIBSC-13/132 Antibodies, Human, to Toxoplasma gondii (4th International Standard) 1EA
WY-NIBSC-13/134 Influenza Antigen B/Massachusetts/02/2012 (Egg derived) 1EA
WY-NIBSC-13/146 C-Peptide, Human (1st International Standard) 1EA
WY-NIBSC-13/148 IVIG + anti-D for use with negative control IVIG 1EA
WY-NIBSC-13/152 Influenza Antigen B/Massachusetts/02/2012 (Cell Derived) 1EA
WY-NIBSC-13/162 Influenza Antigen A/Texas/50/2012 (NYMC X-223A) (Cell derived) 1EA
WY-NIBSC-13/164 Influenza Antigen A/California/7/2009 (H1N1pdm)(NYMC X-179A) 1EA
WY-NIBSC-13/166 Influenza anti-A/Anhui/1/2013 (N9) NA Serum 1EA
WY-NIBSC-13/172 Lupus Anticoagulant (1st International Reference Panel) 1EA
WY-NIBSC-13/176 Influenza Virus Infectious NIBRG-88 1EA
WY-NIBSC-13/178 Influenza Anti-A/Texas/50/2012-like HA Serum 1EA
WY-NIBSC-13/182 Influenza Anti-B/Massachusetts/02/2012-like HA Serum 1EA
WY-NIBSC-13/200 Influenza Virus Infectious NIB-74 1EA
WY-NIBSC-13/202 Influenza Virus Infectious NIB-74xp 1EA
WY-NIBSC-13/204 TNF Rec II- FC Fusion protein (1st International Standard) 1EA
WY-NIBSC-13/206 Plasmin (4th International Standard) 1EA
WY-NIBSC-13/212 Diphtheria Toxoid for use in Flocculation Test (3rd International Standard) 1EA
WY-NIBSC-13/214 HIV-1 Circulating Recombinant Forms RNA (1st International Reference Panel) 1EA
WY-NIBSC-13/216 Anti-meningococcal factor H binding protein variant 1 (JAR5) monoclonal 1EA
WY-NIBSC-13/218 Polio Anti Sabin type 1 (inactivated) Serum 1EA
WY-NIBSC-13/220 Polio Anti Sabin type 2 (inactivated) serum 1EA
WY-NIBSC-13/222 Polio Anti Sabin type 3 (inactivated) serum 1EA
WY-NIBSC-13/224 Influenza virus Infectious NIB-85. 36210 E5 1EA
WY-NIBSC-13/228 Influenza Virus Infectious. A/Almaty/2958/2013. 35790 E4 1EA
WY-NIBSC-13/234 Influenza antigen B/Brisbane/60/08 1EA
WY-NIBSC-13/238 Anti-EV71 serum LOW (WHO Reference Reagent) 1EA
WY-NIBSC-13/240 Tetanus Immunoglobulin, Human (2nd WHO International Standard) 1EA
WY-NIBSC-13/242 FEIBA Concentrate 2nd NIBSC Working Reference Standard 1EA
WY-NIBSC-13/246 Meningococcal serogroup A polysaccharide (1st WHO International Standard) 1EA
WY-NIBSC-13/248 Influenza virus infectious NIBRG-267 (H7N9) 1EA
WY-NIBSC-13/250 Influenza Virus Infectious NIBRG-268 (H7N9) 1EA
WY-NIBSC-13/252 Influenza virus infectious NYMC X-223A 1EA
WY-NIBSC-13/258 Influenza virus infectious NYMC X-233A 1EA
WY-NIBSC-13/262 Meningococcal serogroup A polysaccharide 1EA
WY-NIBSC-13/264 Influenza Virus Infectious NYMC X-223 1EA
WY-NIBSC-13/B627 QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1 1EA
WY-NIBSC-13/B629 QCRHBeQC1 Anti-HBe Control Serum: sample1 1EA
WY-NIBSC-13/B634 QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2 1EA
WY-NIBSC-13/B640 QCRHIV1QC5 - Anti-HIV-1 Quality Control Reagent Sample 5 1EA
WY-NIBSC-13/B642 QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample 1 1EA
WY-NIBSC-13/B644 QCRHIV1QC3-Anti-HIV1:Quality Control Serum:Sample 3 1EA
WY-NIBSC-14/100 Human Papillomavirus (HPV) 11 DNA (1st International Standard) 1EA
WY-NIBSC-14/104 Human Papillomavirus (HPV) Type 45 DNA (1st International Standard) 1EA
WY-NIBSC-14/106 Influenza virus infectious. NYMC BX-51B 1EA
WY-NIBSC-14/114 JC Virus (JCV) DNA (1st International Standard) 1EA
WY-NIBSC-14/116 Influenza virus infectious NYMC X-179A 1EA
WY-NIBSC-14/118 Influenza virus infectious B/Massachusetts/2/2012 1EA
WY-NIBSC-14/140 1st International Standard for Anti EV71 Serum Human 1EA
WY-NIBSC-14/144 Influenza anti-N2 Neuraminidase serum (A/Victoria/361/2011) 1EA
WY-NIBSC-14/146 Influenza Antigen B/Brisbane/60/2008 (NYMCBX-35)(Cell Derived) 1EA
WY-NIBSC-14/148 Human Blood Factor IX Concentrate (5th International Standard) 1EA
WY-NIBSC-14/156 Meningococcal group X polysaccharide (1st WHO International Standard) 1EA
WY-NIBSC-14/160 High titre anti-A in IVIG working reference reagent 1EA
WY-NIBSC-14/174 Botulinum Type A Antitoxin, Equine 1EA
WY-NIBSC-14/200 Influenza Antigen A/Puerto Rico/8/34 (HINI) 1EA
WY-NIBSC-14/206 Influenza virus infectious NYMC X-247 1EA
WY-NIBSC-14/210 Biological activities of Rituximab WHO 1st International Standard 1EA
WY-NIBSC-14/212 BK Virus (BKV)(1st International Standard) 1EA
WY-NIBSC-14/224 Influenza virus infectious. A/Switzerland/9715293/2013 1EA
WY-NIBSC-14/226 Influenza Virus Infectious A/South Australia/55/2014 1EA
WY-NIBSC-14/228 Influenza Virus Infectious A/Stockholm/6/2014 1EA
WY-NIBSC-14/230 Influenza Virus Infectious. A/Norway/466/2014 1EA
WY-NIBSC-14/232 Influenza Virus Infectious IVR-175 1EA
WY-NIBSC-14/238 Recombinant Tissue factor 1EA
WY-NIBSC-14/254 Influenza Antigen A/Switzerland/9715293/2013 (NIB88) 1EA
WY-NIBSC-14/256 Human Papillomavirus (HPV) Type 6 DNA (1st International Standard) 1EA
WY-NIBSC-14/258 Human Papillomavirus (HPV) Type 31 DNA (1st International Standard) 1EA
WY-NIBSC-14/260 Human Papillomavirus (HPV) Type 33 DNA (1st International Standard) 1EA
WY-NIBSC-14/262 Human Papillomavirus (HPV) Type 52 DNA (1st International Standard) 1EA
WY-NIBSC-14/264 Human Papillomavirus (HPV) Type 58 DNA (1st International Standard) 1EA
WY-NIBSC-14/274 Influenza Antigen B/Brisbane/9/2014 (Egg Derived) 1EA
WY-NIBSC-14/300 High titre anti-A and anti-B in serum (WHO Reference Reagent) 1EA
WY-NIBSC-14/306 Influenza Virus Infectious NYMC X-243 40180 E13 1EA
WY-NIBSC-14/308 Influenza Virus Infectious IVR-178 40200 E7 1EA
WY-NIBSC-14/314 Influenza Virus Infectious NIB-88 1EA
WY-NIBSC-14/316 Factor IX activated (FIXa) 2nd WHO International Standard 1EA
WY-NIBSC-14/318 Influenza Anti NIBRG-301 (H5) HA Serum (Sheep SH624 and SH625) 1EA
WY-NIBSC-14/322 Influenza Virus Infectious NIB-91 1EA
WY-NIBSC-14/B651 QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2 1EA
WY-NIBSC-14/B653 QCRHIV2QC3- Anti HIV2: Quality Control Serum: Sample 3 1EA
WY-NIBSC-14/B654 QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample 1 1EA
WY-NIBSC-14/B655 QCRVZVQC1-Anti VZV: Quality Control Serum: Sample 1 1EA
WY-NIBSC-15/100 Influenza Antigen B/Utah/9/2014 (Cell Derived) 1EA
WY-NIBSC-15/102 Activated Blood Coagulation Factor X (FXa), Human 1EA
WY-NIBSC-15/104 Influenza Antigen A/South Australia/55/2014 Cell derived 1EA
WY-NIBSC-15/106 Ancrod 1EA
WY-NIBSC-15/126 Bordetella pertussis toxin (20μg). (2nd International Standard) 1EA
WY-NIBSC-15/130 Clinical Virology Multiplex I: Immunodeficiency panel working reagent for Nucleic Acid Amplification Tests (NAT) 1EA
WY-NIBSC-15/134 Influenza Anti-A Switzerland/9715293/2013-Like HA serum 1EA
WY-NIBSC-15/136 EBOV RNA NP-VP35-GP in-run control 1EA
WY-NIBSC-15/138 EBOV RNA VP40-L in-run control 1EA
WY-NIBSC-15/140 Batroxobin 1EA
WY-NIBSC-15/148 Influenza Virus Infectious NIB-92 1EA
WY-NIBSC-15/154 Influenza Virus Infectious NIB-93 1EA
WY-NIBSC-15/158 Influenza Virus Infectious NYMC X-263 1EA
WY-NIBSC-15/160 Influenza Virus Infectious NIBRG-306 1EA
WY-NIBSC-15/174 Lupus (oligo-specific) anti-dsDNA antibodies WHO Reference Reagent 1EA
WY-NIBSC-15/180 Blood Coagulation Factor XI, 2016 Plasma Human (2nd International Standard). Blood Coagulation Factor XII, 2017 Plasma, Human (1st International Standard) 1EA
WY-NIBSC-15/182 7th British Working Standard for Blood Coagulation Factors II, IX, X Concentrate 1EA
WY-NIBSC-15/184 Influenza Virus Infectious NYMC X-263B 1EA
WY-NIBSC-15/188 Influenza Virus Infectious NYMC X-263A 1EA
WY-NIBSC-15/194 Influenza Virus Infectious NYMC X-257A 1EA
WY-NIBSC-15/196 Influenza Virus Infectious NYMC X-261 1EA
WY-NIBSC-15/212 Influenza Virus Infectious NYMC BX-53C 1EA
WY-NIBSC-15/220 Anti-EBOV plasma, human (WHO Reference Reagent) 1EA
WY-NIBSC-15/222 EBOV RNA NP-VP35-GP (WHO Reference Reagent) 1EA
WY-NIBSC-15/224 EBOV RNA VP40-L (WHO Reference Reagent) 1EA
WY-NIBSC-15/234 Influenza Virus Infectious B/Texas/2/2013 41340 E7 1EA
WY-NIBSC-15/238 Influenza Antigen A/New Caledonia/71/2014 (NYMCX-257A)(Egg derived antigen) 1EA
WY-NIBSC-15/240 Erythropoietin Antibody Reference Panel A (1st WHO Reference Panel) 1EA
WY-NIBSC-15/242 Erythropoietin Antibody Reference Panel B (1st WHO Reference Panel) 1EA
WY-NIBSC-15/248 Influenza Anti A/Anhui/1/2013 (H7) HA Serum (Sheep SH644 & SH645) 1EA
WY-NIBSC-15/250 Influenza Virus Infectious NYMC BX-31 1EA
WY-NIBSC-15/252 Influenza Virus Infectious A/California/7/2009 1EA
WY-NIBSC-15/262 1st International Standard for Ebola virus (EBOV) antibodies Sierra Leone Convalescent Plasma Pool 1EA
WY-NIBSC-15/266 HHV-6 Virus 1st WHO International Standard 1EA
WY-NIBSC-15/270 1st WHO International Reference Reagent CD4 T-cells (human) 1EA
WY-NIBSC-15/272 ICS Positive Control-Lymphocytes 1EA
WY-NIBSC-15/276 Hepatitis A Virus VL For Nucleic Acid Amplification Techniques (3rd International Standard) 1EA
WY-NIBSC-15/294 Influenza virus infectious NYMC BX-59B 1EA
WY-NIBSC-15/296 Sabin monovalent Polio vaccine type 2 (1st International Standard) 1EA
WY-NIBSC-15/300 Influenza Virus Infectious NYMC BX-35 41950 E11 1EA
WY-NIBSC-15/304 Parathyroid hormone 1-34, recombinant, human, 2nd WHO International Standard 1EA
WY-NIBSC-15/B658 QCRLYMEQC1 - Anti-Lyme QC1 1EA
WY-NIBSC-15/B664 QCRMUMPSQC1 - Anti-Mumps Quality Control Reagent Sample 1 1EA
WY-NIBSC-15/B667 QCRMEASQC1 Anti-Measles QC1 1EA
WY-NIBSC-15/B671 QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1 1EA
WY-NIBSC-15/B678 QCRPARVB19QC1 Anti-Parvovirus B19QC1 1EA
WY-NIBSC-16/104 Norovirus GII Working reagent for Nucleic Acid Amplification Techniques 1EA
WY-NIBSC-16/106 Influenza antigen A/California/7/09 (H1N1) (NYMC-X181) 1EA
WY-NIBSC-16/108 Influenza Virus Infectious A/PR/8/34 1EA
WY-NIBSC-16/110 Zika Virus Working Reagent for Nucleic Acid Amplification Testing (NAT) 1EA
WY-NIBSC-16/114 Influenza anti - A/California/7/09 HA serum 1EA
WY-NIBSC-16/118 Influenza Antigen B/Brisbane/60/2008 (NYMC BX-35) (Egg Derived) 1EA
WY-NIBSC-16/120 WHO 1st International Reference Panel for Genomic JAK2 V617F 1EA
WY-NIBSC-16/126 Native Vi polysaccharide (S. Typhi) (1st International Standard) 1EA
WY-NIBSC-16/138 Anti-Typhoid capsular Vi polysaccharide Ig (Human) 1st WHO International Standard 1EA
WY-NIBSC-16/152 Meningococcal Serogroup W Polysaccharide 1EA
WY-NIBSC-16/164 Sabin bivalnet Polio vaccines types 1 and 3 (1st International Standard) 1EA
WY-NIBSC-16/170 Infliximab (1st International Standard) 1EA
WY-NIBSC-16/182 Influenza Anti-A/Hong Kong/4801/2014-like HA Serum 1EA
WY-NIBSC-16/192 Influenza Anti - B/Brisbane/60/2008-HA serum 1EA
WY-NIBSC-16/194 HIV-1 RNA (4th International Standard) 1EA
WY-NIBSC-16/196 Sabin monovalent Polio vaccine type 1(1st International Standard) 1EA
WY-NIBSC-16/200 Influenza Virus Infectious NIB-58 1EA
WY-NIBSC-16/202 OPV reference mOPV 3 1EA
WY-NIBSC-16/204 7th WHO International Standard for Rabies Vaccine 1EA
WY-NIBSC-16/206 Meningococcal serogroup Y Polysaccharide 1EA
WY-NIBSC-16/208 Influenza Virus Infectious NIB-97 42090 E7 1EA
WY-NIBSC-16/210 HIV-1 P24 Antigen (1st international reference panel) 1EA
WY-NIBSC-16/236 HIV-2 p26 Antigen (VLP)-HIV-2 A7312 (1st WHO Reference Reagent) 1EA
WY-NIBSC-16/238 Influenza Antigen A/Anhui/1/2013 (NIBRG-268) (H7N9) 1EA
WY-NIBSC-16/242 Influenza Virus Infectious NIB-98 42110 E7 1EA
WY-NIBSC-16/250 1st International Reference Panel for genomic KRAS codons 12 and 13 mutations 1EA
WY-NIBSC-16/268 Influenza Virus Infectious X-273 1EA
WY-NIBSC-16/270 Influenza Virus Infectious IVR-180 42400 E3/D7/E1 1EA
WY-NIBSC-16/274 Influenza Virus Infectious X-275A 42010 E13 1EA
WY-NIBSC-16/278 Anti-D Immunglobulin control preparation 1EA
WY-NIBSC-16/282 Influenza Virus Infectious X-285 42430 ExE1 1EA
WY-NIBSC-16/286 Influenza Antigen A/Hong Kong/4801/2014 (NYMC X-263B) 1EA
WY-NIBSC-16/288 Influenza Virus Infectious X-283A 42420 ExE1 1EA
WY-NIBSC-16/290 Influenza Virus Infectious X-285A 42440 ExE1 1EA
WY-NIBSC-16/292 Influenza Antigen A/Singapore/GP1908/2015 (IVR-180) 1EA
WY-NIBSC-16/296 Human Immunodeficiency Virus type 2 RNA (HIV-2) for Nucleic Acid Amplification Techniques (2nd International Standard) 1EA
WY-NIBSC-16/302 Tetanus Toxoid for use in Flocculation Test (3rd International Standard) 1EA
WY-NIBSC-16/320 Zika Antibody Working reagent 1EA
WY-NIBSC-16/324 Human Adenovirus DNA for nucleic acid amplification techniques (1st WHO international Standard) 1EA
WY-NIBSC-16/332 Anti-D Immunoglobulin (Replacement IS) 1EA
WY-NIBSC-16/344 WHO Anti-EBOV Convalescent Plasma (International Reference Panel) 1EA
WY-NIBSC-16/352 Anti-Asian Lineage Zika Virus Antibody (human) (1st international standard) 1EA
WY-NIBSC-16/358 Streptokinase (4th WHO International Standard) 1EA
WY-NIBSC-16/360 Influenza Virus Infectious NIB-96 41920 E7 1EA
WY-NIBSC-16/362 Influenza Virus Infectious NYMC X-291 42530 E8 1EA
WY-NIBSC-16/364 3rd International Standard for Prekallikrein Activator 1EA
WY-NIBSC-16/366 Influenza Virus Infectious NYMC X-291A 42540 E8 1EA
WY-NIBSC-16/368 HSV-1 1EA
WY-NIBSC-16/374 Blood Coagulation Factor V, Plasma, Human. (WHO 2nd International Standard) 1EA
WY-NIBSC-16/376 Plasmodium falciparum antigens (1st International Standard) 1EA
WY-NIBSC-16/B687 QCRHIV1RTDQC1- Anti-HIV1 Quality Control Serum: Sample 1 for Rapid Test Devices 1EA
WY-NIBSC-16/B693 QCRCMVIgMQC1 IgM Anti-CMV QC1 1EA
WY-NIBSC-16/B697 QCREBVVCAQC1 1EA
WY-NIBSC-16/B704 QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1 1EA
WY-NIBSC-1-7 Fimbrae monoclonal antibody, clone 1-7 1EA
WY-NIBSC-17/100 Prostate Specific Antigen (human)(total: PSA-ACT + free PSA) 1EA
WY-NIBSC-17/102 Prostate Specific Antigen (human) (Free), (2nd WHO International Standard) 1EA
WY-NIBSC-17/106 Influenza Anti-A/Michigan/45/2015-like HA Serum 1EA
WY-NIBSC-17/122 HSV-2 1EA
WY-NIBSC-17/124 Influenza Virus Infectious NYMC BX-63 42790 E10/E1 1EA
WY-NIBSC-17/126 Influenza Virus Infectious NYMC BX-63A 42780 E10/E1 1EA
WY-NIBSC-17/132 Influenza Anti NIBRG-306 (H5) HA Serum (sheep SH672 and SH637) 1EA
WY-NIBSC-17/136 Influenza Virus Infectious NIBRG-375 (H7N9) 1EA
WY-NIBSC-17/142 Influenza Antigen A/Duck Vietnam/NCVD-1584/2012 (NIBRG-301) (H5N1) 1EA
WY-NIBSC-17/154 Influenza Antigen A/Michigan/45/2015 (NYMC X-275) 1EA
WY-NIBSC-17/156 Influenza Virus Infectious CNIC-1701 42910 E9 1EA
WY-NIBSC-17/162 Influenza Virus Infectious NYMC X-299 42920 E10 1EA
WY-NIBSC-17/164 Influenza Virus Infectious B/Maryland/15/2016 42800 E5 1EA
WY-NIBSC-17/182 Influenza Antigen A/Michigan/45/2015 (NYMC X-275) 1EA
WY-NIBSC-17/184 Influenza Virus Infectious NIB-103 42610 E7 1EA
WY-NIBSC-17/190 Influenza Virus Infectious NYMC X-297 42940 E11 1EA
WY-NIBSC-17/194 Influenza Virus Infectious NIB-104 1EA
WY-NIBSC-17/204 1st International Standard for Darbepoetin 1EA
WY-NIBSC-17/206 14th British Standard for Coagulation Factor VIII Concentrate, Human 1EA
WY-NIBSC-17/210 Influenza Virus Infectious IVR-186 43310 E8 1EA
WY-NIBSC-17/232 Tumor Necrosis Factor alpha (human rDNA derived) 1EA
WY-NIBSC-17/236 Adalimumab (1st WHO International Standard) 1EA
WY-NIBSC-17/240 5% Immunoglobulin (Negative Control) 1EA
WY-NIBSC-17/246 Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (NIB-104) 1EA
WY-NIBSC-17/252 Influenza Virus Infectious NYMC BX-69 43220 E13 1EA
WY-NIBSC-17/256 Influenza Virus Infectious NYMC BX-69A 1EA
WY-NIBSC-17/258 Influenza Virus Infectious B/Alabama/2/2017 1EA
WY-NIBSC-17/264 Influenza Virus Infectious A/Michigan/45/2015 43470 E5 1EA
WY-NIBSC-17/B710 QCRTOXOQC1 - Anti-Toxoplasma gondii Quality Control Reagent Sample 1 1EA
WY-NIBSC-17/B713 QCRSYPHQC2-Anti-Syphilis Quality Control Serum: sample 2 1EA
WY-NIBSC-17/B717 QCRHBsGQC1-HBsAg Quality Control Serum: Sample1 1EA
WY-NIBSC-17/B723 QCRHEVQC1 - Anti-Hepatitis E Quality Control Sample 1 1EA
WY-NIBSC-17/B725 QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1 1EA
WY-NIBSC-17/B728 QCRHEVIgMQC1 - IgM Anti-Hepatitis E Quality Control Sample 1 1EA
WY-NIBSC-18/100 Influenza Antigen B/Maryland/15/2016 1EA
WY-NIBSC-18/104 Influenza Antigen B/Maryland/15/2016 (NYMC BX-69A) 1EA
WY-NIBSC-18/108 Influenza anti-A/Singapore/INFIMH-16-0019/2016- like HA serum 1EA
WY-NIBSC-18/110 Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (IVR-186) 1EA
WY-NIBSC-18/112 Influenza anti-A/Guangdong-17SF003/2016 (H7) (NIBRG-375) HA Serum 1EA
WY-NIBSC-18/116 WHO International Standard Enterovirus 71 (EV71) Inactivated vaccine (Geno Group C4) 1EA
WY-NIBSC-18/118 1st International Standard for HCT 15 Cancer Genome 1EA
WY-NIBSC-18/120 WHO Reference Reagent Enterovirus 71 (EV71) Inactivated Vaccine (Geno Group C4) 1EA
WY-NIBSC-18/130 1st International Standard for MOLT-4 Cancer Genome 1EA
WY-NIBSC-18/132D WHO Reference Reagent Lentiviral Vector Copy number by digital PCR 6.75 log 10 LV copies/ampoule 1EA
WY-NIBSC-18/132Q WHO Reference Reagent Lentiviral Vector Copy number by quantitative PCR 6.89 log 10 LV copies/ampoule 1EA
WY-NIBSC-18/134 Influenza Virus Infectious NIBRG-301 (H5N1) 1EA
WY-NIBSC-18/136 Influenza Virus Infectious NIBRG-14 (H5N1) 1EA
WY-NIBSC-18/138 Influenza Virus Infectious NYMC X-307A 1EA
WY-NIBSC-18/140 Influenza Virus Infectious NYMC X-307 1EA
WY-NIBSC-18/144 WHO 1st Reference Reagent for Lentiviral Vector Integration Site Analysis 1EA
WY-NIBSC-18/146 Pertussis antiserum (human) panel 1EA
WY-NIBSC-18/154 Bordetella pertussis, pertactin, PRN 1EA
WY-NIBSC-18/156 WHO Reference Reagent Enterovirus 71 (EV71) Inactivated Vaccine (Geno Group B4) 1EA
WY-NIBSC-18/160 Influenza Virus Infectious NYMC X-311 1EA
WY-NIBSC-18/164 1st International Standard for ATDB102 Genome 1EA
WY-NIBSC-18/166 Influenza Virus Infectious NIB-112 43990 E6 1EA
WY-NIBSC-18/168 Influenza Virus Infectious A/Switzerland/8060/2017 1EA
WY-NIBSC-18/170 Influenza anti-B/Colorado/06/2017-like HA serum 1EA
WY-NIBSC-18/174 Influenza Virus Infectious A/Brisbane/1/2018 1EA
WY-NIBSC-18/180 2nd International Standard for Diphtheria Antitoxin Equine 1EA
WY-NIBSC-18/184 Hepatitis C virus RNA for nucleic acid amplification techniques (6th WHO International Standard) 1EA
WY-NIBSC-18/188 Influenza Antigen A / Switzerland / 8060 / 2017 (NIB-112) 1EA
WY-NIBSC-18/190 Influenza Antigen A / Brisbane/ 01/2018 (NYMC X-311) 1EA
WY-NIBSC-18/192 Influenza Anti-A/Switzerland/8060/2017-like (H3N2) HA Serum 1EA
WY-NIBSC-18/194 Influenza Virus Infectious NYMC X-275 (Influenza Reagent) 1EA
WY-NIBSC-18/196 Influenza Antigen A/Guangdong/17SF003/2016. NIBRG-375 (H7N9) 1EA
WY-NIBSC-18/208 WHO Reference Reagent for West Nile Virus lineage 2 RNA for NAT-based assays 1EA
WY-NIBSC-18/210 Bevacizumab (1st WHO International Standard) 1EA
WY-NIBSC-18/220 Anti-HPA 15b minimum potency reagent (WHO Reference Reagent) 1EA
WY-NIBSC-18/226 Influenza Virus Infectious IVR-190 44250 E12 1EA
WY-NIBSC-18/230 Influenza Virus Infectious B/Colorado/06/2017 43460 E7 1EA
WY-NIBSC-18/234 Influenza Virus Infectious NIB116-B 44230 E5 1EA
WY-NIBSC-18/236 Influenza Virus Infectious A/Brisbane/02/2018 1EA
WY-NIBSC-18/238 Influenza Antigen A/Brisbane/02/2018 (IVR-190) (H1N1) 1EA
WY-NIBSC-18/240 Influenza Virus Infectious NYMC X-327 44280 E17 1EA
WY-NIBSC-18/242 Influenza Virus Infectious A/Kansas/14/2017 43880 E8 1EA
WY-NIBSC-18/244 Human Chorionic Gonadotropin (hCG) (6th International Standard) 1EA
WY-NIBSC-18/248 Von Willebrand Factor Concentrate (WHO 3rd International Standard) 1EA
WY-NIBSC-18/B732 QCRNEGQC1-Negative Quality Control Serum: Sample1 1EA
WY-NIBSC-18/B733 QCREBVIgMQC1 1EA
WY-NIBSC-18/B742 QCRLYMEIgMQC1 IgM Anti-Lyme QC1 1EA
WY-NIBSC-19/102 Influenza anti-A/Brisbane/02/2018-like (H1N1) HA Serum (Sheep 698, 699, 700, 701) 1EA
WY-NIBSC-19/104 Influenza antigen A/Kansas/14/2017 (NYMC X-327) (H3N2) 1EA
WY-NIBSC-19/106 Influenza Virus Infectious IVR-195 44300 E9 1EA
WY-NIBSC-19/108 Trastuzumab (1st WHO international Standard) 1EA
WY-NIBSC-19/112 Influenza Virus Infectious NIB-110 1EA
WY-NIBSC-19/116 1st WHO Plasmodium Vivax Antigen (LDH) 1EA
WY-NIBSC-19/118 Ferritin (Human, Recombinant) 1EA
WY-NIBSC-19/120 Influenza Virus Infectious X-327 A 44310 E18 1EA
WY-NIBSC-19/146 Influenza Virus Infectious CNIC-1903 1EA
WY-NIBSC-19/148 Influenza Virus Infectious CNIC-1902 44320 E10 1EA
WY-NIBSC-19/152 Influenza anti-A/Kansas/14/2017 - Like (H3N2) HA Serum 1EA
WY-NIBSC-19/154 Influenza Antigen A/Kansas/ 12/2017 (IVR-195) (H3N2) 1EA
WY-NIBSC-19/156 Panel of recombinant antibody controls for Cytokine Release Assays 1EA
WY-NIBSC-19/160 Influenza Virus Infectious A/California/7/09 44430 E6 1EA
WY-NIBSC-19/164 VZV Nucleic acid amplification techniques (1st WHO International Standard) 1EA
WY-NIBSC-19/172 Influenza Virus Infectious BVR-11 1EA
WY-NIBSC-19/174 Influenza Virus Infectious IVR-197 (H3N2) 44850 E14 1EA
WY-NIBSC-19/176 Influenza Virus Infectious B/Victoria/705/2018 1EA
WY-NIBSC-19/178 1st WHO International Standard for Anti-MERS-CoV Immunoglobulin G (Human) 1EA
WY-NIBSC-19/180 Non WHO Reference material Working reagent for Anti-MERS-CoV Antibody 1EA
WY-NIBSC-19/188 3rd International Standard Thrombin 1EA
WY-NIBSC-19/192 Influenza Virus Infectious IVR-202 (H3N2) 44880 E10 1EA
WY-NIBSC-19/194 Influenza Virus Infectious B/Brisbane/35/2018 1EA
WY-NIBSC-19/204 Influenza Antigen A/Newcastle/82/2018 (H3N2) (cell derived) 1EA
WY-NIBSC-19/206 Influenza Virus Infectious X-181 45030 E8 1EA
WY-NIBSC-19/208 Influenza Antigen B/Victoria/705/2018 (BVR-11) (B Victoria Lineage) 1EA
WY-NIBSC-19/210 Influenza Antigen B/Darwin/7/2019 (B Victoria Lineage) (Cell Derived) 1EA
WY-NIBSC-19/212 Influenza Antigen A/South Australia/34/2019 (IVR-197) (H3N2) 1EA
WY-NIBSC-19/216 Influenza Anti-A/South Australia/34/2019-Like (H3N2) HA Serum (Sheep 712, 713, 714, 715, 716) 1EA
WY-NIBSC-19/224 Collection of WHO International Standards for Human Papillomavirus (HPV) DNA genotypes HPV16, HPV18, HPV6, HPV11 1EA
WY-NIBSC-19/226 Collection of WHO International Standards for Human Papillomavirus (HPV) DNA genotypes HPV31, HPV33, HPV45, HPV52, HPV58 1EA
WY-NIBSC-19/228 Influenza Virus Infectious A/South Australia/34/2019 1EA
WY-NIBSC-19/230 Influenza Virus Infectious A/Christchurch/516/2019 H3N2 45010 E4 1EA
WY-NIBSC-19/238 Influenza Antigen B/Washington/02/2019 (B Victoria Lineage) 1EA
WY-NIBSC-19/240 British Working Standard for Anti-HCV 1EA
WY-NIBSC-19/244 Third WHO International Standard for Anti-Rabies Immunoglobulin 1EA
WY-NIBSC-19/246 1st International Standard for human vascular endothelial growth factor-165 (VEGF165) 1EA
WY-NIBSC-19/256 Influenza Virus Infectious BX-85C 45230 E13 1EA
WY-NIBSC-19/258 Influenza Virus Infectious CNIC-1906 44910 E3+3/E9/E1 1EA
WY-NIBSC-19/260 Anti-thyroid peroxidase antibodies (1st WHO International Standard) 1EA
WY-NIBSC-19/276 Influenza Virus Infectious NIB-121 (H3N2) 45180 E7/E1/E5 1EA
WY-NIBSC-19/290 First WHO International Standard for anti-human papillomavirus type 33 serum 1EA
WY-NIBSC-19/296 First WHO International Standard for anti-human papillomavirus type 52 serum 1EA
WY-NIBSC-19/298 First WHO International Standard for anti-human papillomavirus type 6 serum 1EA
WY-NIBSC-19/300 First WHO International Standard for anti-human papillomavirus type 58 serum 1EA
WY-NIBSC-19/306 Influenza Antigen A/Victoria/2454/2019 (IVR-207) (H1N1) 1EA
WY-NIBSC-19/308 Influenza Antigen B/Singapore/INFTT-16-0610/2016 (B Yamagata lineage) (cell derived) 1EA
WY-NIBSC-19/312 Influenza Antigen A/Guangdong-Maonan/SWL1536/2019 (CNIC-1909) (H1N1) 1EA
WY-NIBSC-19/314 Influenza Anti-A/ Guangdong-Maonan/SWL 1536/2019-like (H1N1) HA Serum (Sheep 723, 724, 725, 726, 727, 728) 1EA
WY-NIBSC-19/316 Influenza anti-A/hongKong/2671/2019-like (H3N2) HA Serum (Sheep 729, 730, 731, 732, 733, 734) 1EA
WY-NIBSC-19/318 Influenza anti-B/Washington/02/2019-like (B Victoria lineage) HA Serum (Sheep 737, 738, 739, 740, 741, 742) 1EA
WY-NIBSC-19/320 Influenza anti-N2 Neuraminidase Serum (A/South Australia/34/2019) (Sheep 735, 736) 1EA
WY-NIBSC-19/322 Influenza anti-B/Phuket/3073/2013-like (B Yamagata Lineage) HA serum (Sheep 743, 744, 745, 746, 747, 748) 1EA
WY-NIBSC-19/B747 QCRHIV2QC4 - Anti HIV2 Quality Control Serum Sample 4 1EA
WY-NIBSC-19/B754 Anti-Rubella QC2 1EA
WY-NIBSC-20/102 Influenza Virus Infectious IVR-207 (H1N1) 45370 E4/E6/E1 1EA
WY-NIBSC-20/106 Influenza Virus Infectious A/Victoria/2454/2019 (H1N1) 45360 E4/E1 1EA
WY-NIBSC-20/108 Influenza Antigen A/HongKong/2671/2019 (NIB-121)(H3N2) 1EA
WY-NIBSC-20/110 SARS-CoV-2 (NAT) 1EA
WY-NIBSC-20/112 IVIG + Anti-D (13/148)x2 Negative Control IVIG (12/300) x2 1EA
WY-NIBSC-20/132 Influenza Antigen A/HongKong/2671/2019 (IVR-208) (H3N2) 1EA
WY-NIBSC-20/134 Influenza Virus Infectious BX-57 45430 E4/E10/E1 1EA
WY-NIBSC-20/138 Working Reagent for SARS-CoV-2 RNA 1EA
WY-NIBSC-20/146 First WHO International Standard for SARS-CoV-2 RNA 1EA
WY-NIBSC-20/152 First WHO International Standard for Mycobacterium tuberculosis (H37Rv) DNA for NAT-based assays 1EA
WY-NIBSC-20/162 NIBSC Anti-SARS-CoV-2 Antibody Diagnostic Calibrant 1EA
WY-NIBSC-20/164 Influenza Virus Infectious BX-87C (B/VIC) 45460 E3/E10/E1 1EA
WY-NIBSC-20/170 NHS winter Multiplex Working Reagent for Nucleic acid amplification testing (NAT) 1EA
WY-NIBSC-20/174 First WHO International Standard for anti-human papillomavirus type 11 serum 1EA
WY-NIBSC-20/176 First WHO International Standard for anti-human papillomavirus type 31 serum 1EA
WY-NIBSC-20/178 First WHO International Standard for anti-human papillomavirus type 45 serum 1EA
WY-NIBSC-20/180 Influenza A (H1N1) Panel 1EA
WY-NIBSC-20/182 Influenza A (H3N2) Panel 1EA
WY-NIBSC-20/184 Influenza B Panel 1EA
WY-NIBSC-20/186 RSV A Panel 1EA
WY-NIBSC-20/188 RSV B Panel 1EA
WY-NIBSC-20/190 SARS-CoV-2 Panel 1EA
WY-NIBSC-20/202 Anti-Lassa Virus Antibodies (1st International Standard) 1EA
WY-NIBSC-20/214 Influenza Virus Infectious IVR-216 (H1N1) 45630 E4/D6/E1 1EA
WY-NIBSC-20/218 Follicle Stimulating Hormone (3rd International Standard) 1EA
WY-NIBSC-20/220 Influenza Virus Infectious IVR-217 (H1N1) 45640 E4/D6/E1 1EA
WY-NIBSC-20/234 Influenza Anti-A/Victoria/2570/2019-like (H1N1) HA Serum (Sheep 749, 750, 751, 752, 753, 754) 1EA
WY-NIBSC-20/236 Influenza Virus Infectious X-349 (H1N1) E3/E9/E1 45720 1EA
WY-NIBSC-20/238 Influenza Virus Infectious X-349A (H1N1) E3/E11/E1 45730 1EA
WY-NIBSC-20/264 Influenza Virus Infectious X-341 + 1P (H3N2) 1EA
WY-NIBSC-20/292 2nd International Standard for Factor XIII Plasma, Human 1EA
WY-NIBSC-20/294 Influenza Virus Infectious X-347 (H3N2) 1EA
WY-NIBSC-20/296 Influenza Virus Infectious X-347A (H3N2) 1EA
WY-NIBSC-20/302 WHO International Reference Reagent for GUT Microbiome analysis by NGS (Gut-Mix RR) 1EA
WY-NIBSC-20/310 Influenza Virus Infectious A/Cambodia/E0826360/2020 (H3N2) 1EA
WY-NIBSC-20/314 2nd WHO International Standard For Meningococcal Capsular Group C Polysaccharide 1EA
WY-NIBSC-20/318 Influenza Virus Infectious IVR-221 (H3N2) 1EA
WY-NIBSC-20/322 Influenza Virus Infectious A/Singapore/INFIMH-16-0019/2016 (H3N2) 1EA
WY-NIBSC-20/B758 QCRHIV1p24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2 1EA
WY-NIBSC-20/B760 QCRHBsQC1 1EA
WY-NIBSC-20/B762 QCRHIV1QC2 - Anti-HIV Quality Control Serum sample 2 1EA
WY-NIBSC-20/B764 QCRSARSCoV2QC1 1EA
WY-NIBSC-20/B767 QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1 1EA
WY-NIBSC-20/B774 QCRPARVB19IgMQC1 - IgM Anti-Parvovirus B19 Quality Control Reagent 1 1EA
WY-NIBSC-21/100 Influenza Antigen A/Cambodia/e0826360/2020 (IVR-224) (H3N2) 1EA
WY-NIBSC-21/110 Working Reagent for Lassa virus RNA 1EA
WY-NIBSC-21/112 First WHO International Standard for Lassa virus RNA 1EA
WY-NIBSC-21/116 Influenza Antigen A/Tasmania/503/2020 (IVR-221) (H3N2) 1EA
WY-NIBSC-21/118 Influenza anti-A/Cambodia/e0826360/ 2020-Like (H3N2) HA Serum 1EA
WY-NIBSC-21/120 Influenza Anti-A/Victoria/2570/2019-like (H1N1) HA Serum 1EA
WY-NIBSC-21/122 Influenza Virus Infectious X-357A (H3N2) 1EA
WY-NIBSC-21/124 Influenza Virus Infectious B/HongKong/574/2019 (B-Victoria lineage) 1EA
WY-NIBSC-21/130 Influenza Virus Infectious SAN-004A (H3N2) 1EA
WY-NIBSC-21/132 Influenza Virus Infectious B/Phuket/3073/2013 (B-Yamagata lineage) 1EA
WY-NIBSC-21/136 Influenza Antigen B/Phuket/3073/2013 (B Yamagata lineage) 1EA
WY-NIBSC-21/148 Influenza Virus Infectious X-359 (H3N2) 1EA
WY-NIBSC-21/150 Influenza Virus Infectious X-359A (H3N2) 1EA
WY-NIBSC-21/156 Influenza Virus Infectious BX-93A (B-Victoria Lineage) 1EA
WY-NIBSC-21/158 Influenza Virus Infectious BX-93B (B-Victoria Lineage) 1EA
WY-NIBSC-21/160 Influenza Virus Infectious X-353 (H3N2) 1EA
WY-NIBSC-21/164 Influenza Virus Infectious X-355B (H3N2) 1EA
WY-NIBSC-21/166 Influenza Virus Infectious X-355A-CL (H3N2) 1EA
WY-NIBSC-21/170 1st International Standard 2022 for the in vitro bioactivities of Cetuximab 1EA
WY-NIBSC-21/180 Meningococcal Capsular Group W polysaccharide 1EA
WY-NIBSC-21/186 Influenza Virus Infectious A/Tasmania/503/2020 (H3N2) 1EA
WY-NIBSC-21/190 Influenza Virus Infectious X-361A (H3N2) 1EA
WY-NIBSC-21/192 Influenza Virus Infectious BX-97A (B-Victoria Lineage) 1EA
WY-NIBSC-21/194 Influenza Virus Infectious A/Hong Kong/2671/2019 1EA
WY-NIBSC-21/196 Influenza Virus Infectious IVR-224 (H3N2) 1EA
WY-NIBSC-21/204 Influenza Virus Infectious IVR-227 (H3N2) 1EA
WY-NIBSC-21/212 Influenza Virus Infectious A/Darwin/6/2021 (H3N2) 1EA
WY-NIBSC-21/214 Influenza Virus Infectious A/Darwin/9/2021 (H3N2) 1EA
WY-NIBSC-21/216 Influenza Virus Infectious BVR-25 (B-Victoria Lineage) 1EA
WY-NIBSC-21/224 Influenza Virus Infectious B/Austria/1359417/2021 (B/Victoria Lineage) 1EA
WY-NIBSC-21/226 Influenza Virus Infectious NIB-127 (H3N2) 1EA
WY-NIBSC-21/228 Influenza Virus Infectious NIB-126 (H3N2) 1EA
WY-NIBSC-21/230 1st WHO Reference Reagent Tetanus Antitoxin Equine for use in Flocculation Test 1EA
WY-NIBSC-21/238 Influenza Virus Infectious A/Guangdong-Maonan/SWL/1536/2019 (H1N1) 1EA
WY-NIBSC-21/240 Influenza Virus Infectious CNIC-1909 (H1N1) 1EA
WY-NIBSC-21/242 Influenza Virus Infectious B/Singapore/WUH4618/2021 (B-Victoria Lineage) 1EA
WY-NIBSC-21/244 Influenza Virus Infectious B/Michigan/1/2021 (B/Victoria Lineage) 1EA
WY-NIBSC-21/246 Influenza Virus Infectious IVR-228 (H3N2) 1EA
WY-NIBSC-21/248 Influenza Virus Infectious BVR-27 (B-Victoria Lineage) 46580 1EA
WY-NIBSC-21/252 Influenza Virus Infectious IVR-215 (H1N1) 1EA
WY-NIBSC-21/268 Anti-pneumococcal serotype 1 monoclonal antibody (clone13-110A 1EA
WY-NIBSC-21/270 Anti-pneumococcal serotype 3 monoclonal antibody (clone 15-103FC11 IH5) 1EA
WY-NIBSC-21/272 Anti-pneumococcal serotype 5 monoclonal antibody (clone 1366LC1 IE11) 1EA
WY-NIBSC-21/274 Anti-pneumococcal serotype 6A / 6C monoclonal antibody (clone 14-107 JG10 IA1/IB1 IIG10) 1EA
WY-NIBSC-21/276 Anti-pneumococcal serotype 7F monoclonal antibody (clone 15-102HG6 ID8) 1EA
WY-NIBSC-21/278 Anti-pneumococcal serotype 8 monoclonal antibody (clone 7D3) 1EA
WY-NIBSC-21/280 Anti-pneumococcal serotype 9N monoclonal antibody (clone 18-125BG4 ID4) 1EA
WY-NIBSC-21/282 Anti-pneumococcal serotype 9V monoclonal antibody (clone 15-112EG9 IE2) 1EA
WY-NIBSC-21/284 Anti-pneumococcal serotype 10A monoclonal antibody (clone 17-117IA3 IIB6) 1EA
WY-NIBSC-21/286 Anti-pneumococcal serotype 12F monoclonal antibody (clone 1C1) 1EA
WY-NIBSC-21/288 Anti-pneumococcal serotype 14 monoclonal antibody (clone 13-111A) 1EA
WY-NIBSC-21/290 Anti-pneumococcal serotype 18C monoclonal antibody (clone 15-104AG5 IIH4) 1EA
WY-NIBSC-21/292 Anti-pneumococcal serotype 19A monoclonal antibody (clone 14-105IH8 IE12) 1EA
WY-NIBSC-21/294 Anti-pneumococcal serotype 22F monoclonal antibody (clone 17-122 CG1 IC3) 1EA
WY-NIBSC-21/298 Influenza Virus Infectious A/Michigan/173/2020 (H3N2) 1EA
WY-NIBSC-21/306 Influenza Virus Infectious SAN-010 (H3N2) 1EA
WY-NIBSC-21/308 2nd International Standard for Interleukin-6 1EA
WY-NIBSC-21/314 Influenza Antigen A/Darwin/6/2021 (IVR-227) (H3N2) 1EA
WY-NIBSC-21/316 Influenza Antigen B/Austria/1359417/2021 (BVR-26) (B Victoria Lineage) 1EA
WY-NIBSC-21/318 Influenza Antigen A/Darwin/9/2021 (IVR-228) (H3N2) 1EA
WY-NIBSC-21/320 Influenza Antigen A/Darwin/9/2021 (SAN-010) (H3N2) 1EA
WY-NIBSC-21/322 Influenza Anti-B Neuraminidase Serum (B/Phuket/3073/2013) 1EA
WY-NIBSC-21/326 Influenza Anti-B/Austria/1359417/2021 Like (B Victoria Lineage) HA Serum 1EA
WY-NIBSC-21/330 Influenza Antigen B/Michigan/01/2021 1EA
WY-NIBSC-21/332 1st International Reference Panel for anti-Lassa fever virus antibodies 1EA
WY-NIBSC-21/336 Influenza Virus Infectious B/Washington/02/2019 (B-Victoria lineage) 1EA
WY-NIBSC-21/338 1st International Standard 2022 Antibodies to SARS-CoV-2 variants of concern 1EA
WY-NIBSC-21/340 Second WHO International Standard for anti-SARS-CoV-2 immunoglobulin 1EA
WY-NIBSC-21/346 Influenza Virus Infectious A/Victoria/2570/2019 (H1N1) 1EA
WY-NIBSC-21/348 Influenza Virus Infectious B/Utah/9/2014 (B-Yamagata lineage) 1EA
WY-NIBSC-21/350 Influenza Virus Infectious BX-59A (B-Yamagata lineage) 1EA
WY-NIBSC-21/352 Influenza Virus Infectious B/Brisbane/9/2014 (B-Yamagata) 1EA
WY-NIBSC-21/366 Influenza Virus Infectious SAN-011 (H1N1) 1EA
WY-NIBSC-21/368 SARS-Cov-2 Antigen 1st WHO International Standard 1EA
WY-NIBSC-21/380 Influenza Virus Infectious IVR-208 (H3N2) 1EA
WY-NIBSC-21/382 Influenza Virus Infectious X-367A (H3N2) 1EA
WY-NIBSC-21/384 Influenza Virus Infectious X-369A (H3N2) 1EA
WY-NIBSC-21/388 Influenza Virus Infectious B/Guangdong-Zhenjiang/1516/2021 (B-Victoria Lineage) 1EA
WY-NIBSC-21/B777 Ferritin Quality Control Sample 1EA
WY-NIBSC-21/B882 QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1 1EA
WY-NIBSC-21/B889 QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1 1EA
WY-NIBSC-22/100 Influenza Antigen A/Victoria/2570/2019 (IVR-215) (H1N1) 1EA
WY-NIBSC-22/108 Reference Panel for Lassa virus RNA 1EA
WY-NIBSC-22/118 Influenza Virus Infectious NIB-129 (H3N2) 1EA
WY-NIBSC-22/134 Influenza Virus Infectious BX-107A (B-Victoria Lineage) 1EA
WY-NIBSC-22/136 Influenza Virus Infectious A/North Carolina/01/2021 (H1N1) X-375 1EA
WY-NIBSC-22/138 Influenza Virus Infectious A/Indiana/02/2020 (H1N1) 1EA
WY-NIBSC-22/140 Influenza Virus Infectious A/Netherlands 00007/2021 (H3N2) SAN-012 1EA
WY-NIBSC-22/142 Influenza Virus Infectious A/Sydney/5/2021 (H1N1) SAN-013 1EA
WY-NIBSC-22/144 Influenza Virus Infectious A/Darwin/22/2021 (H3N2) SAN-014 1EA
WY-NIBSC-22/146 Influenza Virus Infectious A/Brisbane/02/2018 (H1N1) 1EA
WY-NIBSC-22/148 Meningococcal Capsular Group Y Polysaccharide 1EA
WY-NIBSC-22/154 Influenza Virus Infectious B/Connecticut/01/2021 (B-Victoria Lineage) 1EA
WY-NIBSC-22/156 Influenza Virus Infectious A/Norway/16606/2021 (H3N2) NYMC X-373A 1EA
WY-NIBSC-22/158 Influenza Virus Infectious A/Netherlands/00007/2021 (H3N2) NYMC X-377 1EA
WY-NIBSC-22/172 Influenza Virus Infectious A/Lyon/820/2021 (H1N1) NIB-132 1EA
WY-NIBSC-22/174 Influenza Virus Infectious A/Victoria/2570/2019 (H1N1) NYMC X-379 1EA
WY-NIBSC-22/178 Influenza Virus Infectious A/Darwin/22/2021 (H3N2) NIB -130 1EA
WY-NIBSC-22/180 Influenza Virus Infectious A/Guizhou/Liuzhite/326/2022 (H3N2) CNIC-2206 1EA
WY-NIBSC-22/200 Influenza Virus Infectious A/Sydney/5/2021 (H1N1) 1EA
WY-NIBSC-22/204 Influenza Virus Infectious B/Austria/1359417/2021 (B-Victoria lineage) BVR-26 1EA
WY-NIBSC-22/212 NIBSC Reference Reagent for DNA extractions of gut microbiome samples (WC-Gut-RR) 1EA
WY-NIBSC-22/214 Influenza Virus Infectious CBER-48A (A/Sydney/5/2021) (H1N1) 1EA
WY-NIBSC-22/218 Working Reagent for anti-monkeypox virus antibodies 1EA
WY-NIBSC-22/220 Influenza Antigen A/Sydney/5/2021 (SAN-013) (H1N1) 1EA
WY-NIBSC-22/222 Influenza Antigen A/Sydney/175/2022 (IVR-235) (H1N1) 1EA
WY-NIBSC-22/226 Influenza Anti-A/Darwin/9/2021-like (H3N2) HA Serum 1EA
WY-NIBSC-22/234 Influenza Virus Infectious IVR-235 (A/Sydney/175/2022 (H1N1) 1EA
WY-NIBSC-22/236 Anti-pneumococcal serotype 2 monoclonal antibody (clone 2D1) 1EA
WY-NIBSC-22/238 Anti-pneumococcal serotype 4 monoclonal antibody (clone 14-100JA2 IIE7 2H7) 1EA
WY-NIBSC-22/242 Anti-pneumococcal serotype 11A monoclonal antibody (clone 8G12) 1EA
WY-NIBSC-22/244 Anti-pneumococcal serotype 15B monoclonal antibody (clone 3D3) 1EA
WY-NIBSC-22/246 Anti-pneumococcal serotype 17F monoclonal antibody (clone 17-120DG2 IF2) 1EA
WY-NIBSC-22/248 Anti-pneumococcal serotype 20 monoclonal antibody (clone 18-121 DF9 IIG8 1B6) 1EA
WY-NIBSC-22/250 Anti-pneumococcal serotype 33F monoclonal antibody (clone 3B2) 1EA
WY-NIBSC-22/254 Anti-pneumococcal serotype 6C monoclonal antibody (clone 1B2) 1EA
WY-NIBSC-22/256 Anti-pneumococcal serotype 15A/B monoclonal antibody (clone 3A4) 1EA
WY-NIBSC-22/258 Anti-pneumococcal serotype 16F monoclonal antibody (clone 20-121HC4 IA4 IE6) 1EA
WY-NIBSC-22/260 Anti-pneumococcal serotype 19F monoclonal antibody (clone 8E9- 1B12) 1EA
WY-NIBSC-22/262 Anti-pneumococcal serotype 23F monoclonal antibody (clone 15-113HA6 IG2) 1EA
WY-NIBSC-22/264 Anti-pneumococcal serotype 24F monoclonal antibody (clone 1A6) 1EA
WY-NIBSC-22/266 Anti-pneumococcal serotype 35B monoclonal antibody (clone 3F6) 1EA
WY-NIBSC-22/268 Influenza Virus Infectious SAN-015 (A/Lyon/820/2021) (H1N1) 1EA
WY-NIBSC-22/270 1st International Reference Panel for antibodies to SARS-CoV-2 variants of concern 1EA
WY-NIBSC-22/272 1st International Reference Panel for Infliximab anti-drug antibodies 1EA
WY-NIBSC-22/276 Anti-pneumococcal serotype 2 monoclonal antibody (clone 1G7) 1EA
WY-NIBSC-22/278 Anti-pneumococcal serotype 15B monoclonal antibody (clone 2F4) 1EA
WY-NIBSC-22/280 Anti-pneumococcal serotype 23F monoclonal antibody (clone 15-113HA5 IE2 IE2) 1EA
WY-NIBSC-22/282 Anti-pneumococcal serotype 24F monoclonal antibody (clone 2F2) 1EA
WY-NIBSC-22/284 Anti-pneumococcal serotype CPS monoclonal antibody (clone 14-108BA5 IE10) 1EA
WY-NIBSC-22/286 Anti-pneumococcal serotype 4 monoclonal antibody (clone 14-100JA2 IIE7 2G6) 1EA
WY-NIBSC-22/288 Anti-pneumococcal serotype 5 monoclonal antibody (clone 1366KG3 IA11) 1EA
WY-NIBSC-22/290 Anti-pneumococcal serotype 6B monoclonal antibody (clone 14-102CC2 ID9) 1EA
WY-NIBSC-22/292 Anti-pneumococcal serotype 8 monoclonal antibody (clone 6G1) 1EA
WY-NIBSC-22/294 Anti-pneumococcal serotype 10A monoclonal antibody (clone 17-117DE8 IIE9) 1EA
WY-NIBSC-22/296 Anti-pneumococcal serotype 11A monoclonal antibody (clone 2E2) 1EA
WY-NIBSC-22/298 Anti-pneumococcal serotype 12F monoclonal antibody (clone 1C8) 1EA
WY-NIBSC-22/300 Anti-pneumococcal serotype 15A-B monoclonal antibody (clone 1B4) 1EA
WY-NIBSC-22/302 Anti-pneumococcal serotype 16F monoclonal antibody (clone 20-121EC11 IIF10 VE2) 1EA
WY-NIBSC-22/304 Anti-pneumococcal serotype 17F monoclonal antibody (clone 17-120AE4 IE3 IG2) 1EA
WY-NIBSC-22/306 Anti-pneumococcal serotype 22F monoclonal antibody (clone 17-122 JB11 IB11) 1EA
WY-NIBSC-22/308 Anti-pneumococcal serotype 35B monoclonal antibody (clone 3F9) 1EA
WY-NIBSC-22/312 Influenza Virus Infectious A/Norway/31694/2022 (H1N1) 1EA
WY-NIBSC-22/316 Influenza Virus Infectious A/Victoria/4897/2022 (H1N1) 1EA
WY-NIBSC-22/318 Influenza Virus Infectious IVR-238 (A/Victoria/4897/2022 (H1N1) 1EA
WY-NIBSC-22/320 Influenza Antigen A/Victoria/4897/2022 (IVR-238) (H1N1) 1EA
WY-NIBSC-22/B891 QCRTOXOIgMQC1 IgM Anti-Toxoplasma QC1 1EA
WY-NIBSC-22/B893 QCRHBsGQC2-Anti HBsAg Quality Control Serum: Sample2 1EA
WY-NIBSC-22/B895 QCRHIV2QC2-Anti HIV2: Quality Control Serum: Sample2 1EA
WY-NIBSC-22/B896 Anti-SARS-CoV-2 Verification Panel for Serology Assays 1EA
WY-NIBSC-23/100 Influenza anti-A/Victoria/4897/2022-like (H1N1) HA Serum 1EA
WY-NIBSC-23/112 Influenza Virus Infectious NIB-133 (A/Norway/31694/2022) (H1N1) 1EA
WY-NIBSC-23/120 Influenza Virus Infectious A/Wisconsin/67/2022 (H1N1) 1EA
WY-NIBSC-23/122 Influenza Virus Infectious A/West Virginia/30/2022 (H1N1) 1EA
WY-NIBSC-23/126 Influenza Virus Infectious NIB-134 (A/Catalonia/NSVH161512065/2022 (H1N1) 1EA
WY-NIBSC-234 IPV ELISA MAbs Type 1, 2 and 3 (Type 1; No: 234) 1EA
WY-NIBSC-2BADS Anti-Brucella Abortus Serum, Bovine (International Standard) 1EA
WY-NIBSC-2CPBETAAT Clostridium Perfringens Beta Antitoxin (2nd International Standard) 1EA
WY-NIBSC-2CPEPAT Clostridium Perfringens Epsilon Antitoxin (2nd International Standard) 1EA
WY-NIBSC-32-1 Filamentous Haemagglutinin monoclonal antibody, clone 32-1 1EA
WY-NIBSC-3-5 Pertactin Monoclonal antibody, Clone 3-5 1EA
WY-NIBSC-4024 Antisera to SARS CoV-1 S1 Protein (Rabbit) 1EA
WY-NIBSC-520 IPV ELISA MAbs Type 1, 2 and 3 (Type 3; No: 520) 1EA
WY-NIBSC-59/015 Gas Gangrene (Cl. Perfringens(Cl. Welchii) Type A), Equine 1EA
WY-NIBSC-59/016 Corticotrophin (ACTH), Porcine (3rd International Standard) 1EA
WY-NIBSC-59/021 Botulinum Antitoxin Equine Type A 1EA
WY-NIBSC-60/001 Botulinum Antitoxin Equine Type B 1EA
WY-NIBSC-60/013 Tetanus Antitoxin, Equine, for Bioassay 1EA
WY-NIBSC-62/014 Lysine Vasopressin, Porcine 1EA
WY-NIBSC-629E1 Pertussis toxoid monoclonal antibody, clone 629E1 1EA
WY-NIBSC-63/005 Gas Gangrene Antitoxin (Cl. Histolyticum), Equine 1EA
WY-NIBSC-64/014 Gas Gangrene Antitoxin (Cl. Septicum), Equine 1EA
WY-NIBSC-64/024 Gas Gangrene Antitoxin (Cl. Oedematiens), Equine 1EA
WY-NIBSC-65/093 Anti-Thyroglobulin Serum, Human (WHO Reference reagent) 1EA
WY-NIBSC-65/119 Renin, Porcine 1EA
WY-NIBSC-65/122 Long-acting Thyroid Stimulator, Human 1EA
WY-NIBSC-66/138 Gastrin II, Porcine 1EA
WY-NIBSC-66/153 Diphtheria Antitoxin, Equine 1EA
WY-NIBSC-66/233 Anti-Nuclear Factor Serum (Homogenous) Human 1EA
WY-NIBSC-67/037 Immunoglobulin D (IgD) Serum, Human 1EA
WY-NIBSC-67/099 Immunoglobulins G, A & M Serum Human 1EA
WY-NIBSC-67/182 Anti-Rubella Serum, Human 1EA
WY-NIBSC-67/183 Primary Biliary Cirrhosis Serum, Human 1EA
WY-NIBSC-68/340 Anti-Nucleolar Factor Plasma, Human 1EA
WY-NIBSC-68/356 Renin, Human (International Standard) 1EA
WY-NIBSC-69/065 Autoimmune Antibody to Human Spermatazoa 1EA
WY-NIBSC-69/194 Glucagon, Porcine (First International Standard) 1EA
WY-NIBSC-69K/16 Pertactin monoclonal antibody, clone 69K/16 1EA
WY-NIBSC-70/302 Angiotensin II (25μg) 1EA
WY-NIBSC-71/281 Anti-Malaria Plasma P Vivax 1EA
WY-NIBSC-71/326 Anti-Malaria Plasma Vivax Ng2 1EA
WY-NIBSC-72/092 Anti-malaria Plasma: Plasmodium falciparum (Ghana) 1EA
WY-NIBSC-72/096 Anti-Malaria Serum (P.Malariae) 1EA
WY-NIBSC-72/341 Anti-Malaria Plasma P Falciparum 1EA
WY-NIBSC-72/345 Anti-Malaria Plasma P Falciparum 1EA
WY-NIBSC-72/348 Anti-Malaria Plasma P Vivax 1EA
WY-NIBSC-73/517 Anti-D (Rho) Antibodies, Human 1EA
WY-NIBSC-73/545 Placental Lactogen, Human (International Reference Preparation) 1EA
WY-NIBSC-73/554 Cholera Vaccine (Inaba) 1EA
WY-NIBSC-73/556 Cholera Vaccine (Ogawa) 1EA
WY-NIBSC-74/520 Serum Proteins (Other than Immunoglobulins) Human 1EA
WY-NIBSC-74/581 Ancrod (1st International Reference Preparation) 1EA
WY-NIBSC-75/506 Cocksfoot Pollen Extract 1EA
WY-NIBSC-75/533 Chorionic Gonadotrophin, Human, for Radioiodination 1EA
WY-NIBSC-75/535 Chorionic Gonadotrophin beta, Human, for Radioiodination 1EA
WY-NIBSC-75/551 Chorionic Gonadotrophin beta Subunit, Human (International Reference Preparation) 1EA
WY-NIBSC-75/569 Chorionic Gonadotrophin alpha subunit, Human (International Reference Preparation) 1EA
WY-NIBSC-75/595 Blood Coagulation Factor Xa, Bovine 1EA
WY-NIBSC-76/508 Chorionic Gonadotrophin alpha Subunit, Human, for Radioiodination 1EA
WY-NIBSC-76/515 Mannan (Candida Albicans) Purified 1EA
WY-NIBSC-76/522 Opacity 5IRP WHO International Standard 1EA
WY-NIBSC-76/525 Anti-Birch Pollen Serum, Human 1EA
WY-NIBSC-76/547 Influenza anti A/Victoria/3/75 Serum(goat) 1EA
WY-NIBSC-76/575 Oxytocin(4th International Standard) 1EA
WY-NIBSC-77/503 Anti-Cocksfoot Serum, Human 1EA
WY-NIBSC-77/512 Lysine Vasopressin(1st International Standard) 1EA
WY-NIBSC-77/531 Influenza anti A/New Jersey/8/76(H1N1) Serum 1EA
WY-NIBSC-77/568 Influenza anti B/Hong Kong/8/73 Serum 1EA
WY-NIBSC-77/584 Anti-D Pteronyssinus Serum, Human 1EA
WY-NIBSC-77/600 Mannan (Candida Albicans) Purified 1EA
WY-NIBSC-77/616 Twelve Grass Pollen Extract 1EA
WY-NIBSC-77/643 Secretin 1EA
WY-NIBSC-77/662 Acarus Siro Extract 1EA
WY-NIBSC-77/664 Glycyphagus destructor Extract 1EA
WY-NIBSC-78/517 Tyrophagus Putrescentiae Extract 1EA
WY-NIBSC-78/543 Kininogenase (Porcine, Pancreatic) (Formerly 1st International Standard) 1EA
WY-NIBSC-78/545 Anti-Aspergillus fumigatus Serum, Human 1EA
WY-NIBSC-78/554 Luteinizing Hormone, Pituitary, alpha subunit (International Standard) 1EA
WY-NIBSC-78/556 Luteinizing Hormone, Pituitary, beta subunit (International standard) 1EA
WY-NIBSC-78/560 Influenza Antigen A/Texas/1/77 1EA
WY-NIBSC-78/569 Influenza anti A/Texas/1/77 Serum 1EA
WY-NIBSC-78/575 Aspergillus Fumigatus Extract 1EA
WY-NIBSC-78/582 Tyrophagus Longior Extract 1EA
WY-NIBSC-78/628 Bee Venom 1EA
WY-NIBSC-79/500 Parathyroid Hormone, HumanRef. Preparation) 1EA
WY-NIBSC-79/516 Influenza anti A/Brazil/11/78 Serum (goat) 1EA
WY-NIBSC-79/552 Influenza Antigen A/USSR/92/77 1EA
WY-NIBSC-79/558 Influenza Antigen A/USSR/92/77 1EA
WY-NIBSC-79/560 Influenza Antigen A/Brazil/11/78 1EA
WY-NIBSC-79/568 Influenza Antigen B/Hong Kong/8/73 1EA
WY-NIBSC-79/572 Prekallikrein Activator (PKA), Human 1EA
WY-NIBSC-80/505 Growth Hormone, Human, Pituitary. WHO International Standard 1EA
WY-NIBSC-80/517 Influenza Antigen A/Bangkok/1/79 1EA
WY-NIBSC-80/519 Influenza Antigen B/Singapore/222/79 1EA
WY-NIBSC-80/523 Influenza anti B/Singapore/222/79 Serum 1EA
WY-NIBSC-80/525 Influenza anti A/Bangkok/1/79 Serum 1EA
WY-NIBSC-80/590 Tetracosactide. International Ref. Preparation 1EA
WY-NIBSC-81/535 Luteinizing Hormone, Human, Pituitary (3rd International Standard) 1EA
WY-NIBSC-82/508 Parathyroid Hormone, Human-Type, Synthetic (1-34) fragment 1EA
WY-NIBSC-82/512 Parathyroid Hormone, Bovine-Type, Synthetic (1-34) fragment 1EA
WY-NIBSC-82/518 Dermatophagoides Pteronyssinus Extract. WHO International Standard 1EA
WY-NIBSC-82/520 Timothy Pollen Extract. WHO International Standard 1EA
WY-NIBSC-82/585 Anti Poliovirus serum types 1,2 and 3 (3rd International Standard) 1EA
WY-NIBSC-82/587 Interferon Gamma (Human, Leukocyte derived) 1EA
WY-NIBSC-82/632 Parathyroid Hormone, Bovine. WHO International Standard 1EA
WY-NIBSC-82/652 Human Serum Vitamin B12, Pernicous anaemia 1EA
WY-NIBSC-83/501 Beta Thromboglobulin, Purified Human. WHO International Standard 1EA
WY-NIBSC-83/505 Platelet Factor 4 Human, Purified. WHO International Standard 1EA
WY-NIBSC-83/511 Insulin, Bovine. WHO International Standard 1EA
WY-NIBSC-83/514 Interferon alpha-1D, (Human rDNA derived) WHO International Standard 1EA
WY-NIBSC-83/515 Insulin, Porcine. WHO International Standard 1EA
WY-NIBSC-83/537 Influenza Antigen A/Philippines/2/82 1EA
WY-NIBSC-83/545 Influenza anti A/Philippine/2/82 Serum 1EA
WY-NIBSC-83/550 Influenza Antigen A/Brazil/11/78 1EA
WY-NIBSC-83/573 Prolactin, Human (4th WHO International Standard) 1EA
WY-NIBSC-83/575 Follicle Stimulating Hormone, Pituitary. WHO International Standard 1EA
WY-NIBSC-84/514 Proinsulin, Bovine. International Ref. Preparation 1EA
WY-NIBSC-84/522 Birch Pollen Extract. WHO International Standard 1EA
WY-NIBSC-84/528 Proinsulin, Porcine. International Ref. Reagent 1EA
WY-NIBSC-84/538 Influenza Antigen A/Chile/1/83 1EA
WY-NIBSC-84/542 Influenza Antigen B/Norway/1/84 1EA
WY-NIBSC-84/581 Short Ragweed Pollen Extract. WHO International Standard 1EA
WY-NIBSC-84/614 Calcitonin, ASU 1-7 Eel Calcitonin Analogue (Elcatonin) WHO International Standard 1EA
WY-NIBSC-84/628 Anti-c Serum, Human 1EA
WY-NIBSC-84/636 Influenza anti B/USSR/100/83 Serum 1EA
WY-NIBSC-84/640 Influenza anti A/Chile/1/8 Serum 1EA
WY-NIBSC-84/677 Influenza anti A/equine/Miami/63 (H3N8) Serum(goat) 1EA
WY-NIBSC-84/685 Dog (Canis Familiaris) Hair Dander Extract. WHO International Standard 1EA
WY-NIBSC-85/506 C-Reactive Protein, Human. WHO International Standard 1EA
WY-NIBSC-85/516 Influenza anti A/Equine/Kentucky/1/81 HA Serum 1EA
WY-NIBSC-85/520 Influenza Antigen A/Equine/Kentucky/1/81 1EA
WY-NIBSC-85/522 Thyroid Stimulating Hormone beta subunit 1EA
WY-NIBSC-85/551 Anti-Rye Grass Serum, Human 1EA
WY-NIBSC-85/616 Haemoglobin F Lysate, Raised. WHO Reference Reagent 1EA
WY-NIBSC-85/669 Atrial Natriuretic Factor, Human. WHO International Standard 1EA
WY-NIBSC-86/500 Interleukin- 2 (Human, rDNA derived)(2nd International Standard) 1EA
WY-NIBSC-86/536 Angiotensin I Human Type Synthetic 1EA
WY-NIBSC-86/538 Angiotensin II (2.5μg) 1EA
WY-NIBSC-86/552 Interleukin-1 Beta (Human, rDNA derived) 1EA
WY-NIBSC-86/576 Influenza Antigen A/Mississippi/1/85 1EA
WY-NIBSC-86/590 Influenza anti A/Mississippi/1/85 Serum 1EA
WY-NIBSC-86/592 Influenza anti B/Ann Arbor/1/86/HA Serum 1EA
WY-NIBSC-86/630 Influenza Antigen B/Ann Arbor/ 1/86 1EA
WY-NIBSC-86/632 Interleukin-1 alpha (Human rDNA derived) WHO International Standard 1EA
WY-NIBSC-86/678 Interleukin-1 alpha (Human, rDNA derived) 1EA
WY-NIBSC-86/680 Interleukin-1 beta (Human, rDNA derived) WHO International Standard 1EA
WY-NIBSC-86/690 Inhibin, Porcine WHO International Standard 1EA
WY-NIBSC-87/510 Influenza Antigen A/Equine/Miami/63 1EA
WY-NIBSC-87/578 Influenza anti A/Leningrad/360/86 Serum 1EA
WY-NIBSC-87/584 Influenza Antigen A/Leningrad/360/86 1EA
WY-NIBSC-87/586 Interferon Gamma (Human, rDNA derived) 1EA
WY-NIBSC-87/640 Tumour Necrosis Factor beta (Human, rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-87/654 Anti-Ferritin Monoclonal Antibody (1) 1EA
WY-NIBSC-87/662 Anti-Ferritin Monoclonal Antibody (2) 1EA
WY-NIBSC-87/714 Influenza Antigen A/Sichuan/2/87 1EA
WY-NIBSC-87/774 Influenza Antigen B/Victoria/2/87 1EA
WY-NIBSC-88/522 Bordetella pertussis (Whole cell vaccine) 3BRP 1EA
WY-NIBSC-88/532 Tumour Necrosis Factor alpha (Mouse, rDNA derived) 1EA
WY-NIBSC-88/554 Influenza Antigen B/Beijing/1/87 1EA
WY-NIBSC-88/556 Calcitonin, Eel WHO International Standard 1EA
WY-NIBSC-88/638 Thyroxine-binding globulin. WHO International Standard 1EA
WY-NIBSC-88/646 Granulocyte Macrophage Colony Stimulating Factor (Human, rDNA derived) WHO International Standard 1EA
WY-NIBSC-88/654 Influenza Antigen A/England/427/88 1EA
WY-NIBSC-88/656 Interleukin-4 (Human, rDNA derived) WHO International Standard 1EA
WY-NIBSC-88/672 Influenza anti A/Sichuan/2/87 Serum 1EA
WY-NIBSC-88/678 Influenza anti B/Beijing/1/87 Serum 1EA
WY-NIBSC-88/846 Influenza anti A/England/427/88 Serum 1EA
WY-NIBSC-89/512 Macrophage Colony Stimulating Factor (CSF-1) (Human rDNA derived) WHO International Standard 1EA
WY-NIBSC-89/514 Transforming Growth Factor beta-1 (Human, rDNA derived) 1EA
WY-NIBSC-89/516 Transforming Growth Factor beta-1 (Bovine) 1EA
WY-NIBSC-89/518 Transforming Growth Factor beta-2 (Bovine) 1EA
WY-NIBSC-89/520 Interleukin-8 (Human, rDNA derived) WHO International Standard 1EA
WY-NIBSC-89/530 Anti-Bordetella pertussis serum (Human) 1EA
WY-NIBSC-89/544 Renin, Human, rec DNA 1EA
WY-NIBSC-89/568 Influenza Antigen A/OMS/5389/88 1EA
WY-NIBSC-89/594 Bordetella pertussis (W28) LPS 2ug 1EA
WY-NIBSC-89/596 Bordetella pertussis anti-agglutinogen 1(rabbit) 1EA
WY-NIBSC-89/598 Bordetella pertussis anti-agglutinogen 2 (rabbit) 1EA
WY-NIBSC-89/600 Bordetella pertussis anti-agglutinogen 3 (rabbit) 1EA
WY-NIBSC-89/620 Calcitonin, Human. WHO International Standard 1EA
WY-NIBSC-89/666 Haemoglobin A2 Lysate, Raised. WHO Reference Reagent 1EA
WY-NIBSC-89/670 Bordetella pertussis (W28) LPS25ug 1EA
WY-NIBSC-8E1-1H1.2.1 Tetanus toxoid monoclonal antibody, clone 8E1-1H1.2.1 1EA
WY-NIBSC-90/500 Influenza Antigen A/Shanghai/16/89 1EA
WY-NIBSC-90/502 Influenza Antigen A/Guizhou/54/89 1EA
WY-NIBSC-90/504 Influenza anti A/Guangdong/39/89 Serum 1EA
WY-NIBSC-90/520 Bordetella pertussis, filamentous haemagglutinin (FHA) 1EA
WY-NIBSC-90/530 Interleukin-7 (Human, rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-90/534 Mumps Vaccine (Live) WHO Reference Reagent 1EA
WY-NIBSC-90/586 Interleukin-5 (Human, rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-90/636 HIV-1 P24 Antigen WHO International Standard 1EA
WY-NIBSC-90/690 Anti-Varicella-Zoster Antibody 1EA
WY-NIBSC-90/696 Transforming Growth Factor beta-2, Human, rec DNA 1EA
WY-NIBSC-90/712 Basic Fibroblast Growth Factor (Human, rDNA derived) WHO International Standard 1EA
WY-NIBSC-90/784 Influenza Virus infectious NIB-26 (H3N2) 1EA
WY-NIBSC-91/510 Interleukin-3 (Human, rDNA derived) WHO International Standard 1EA
WY-NIBSC-91/530 Epidermal Growth Factor (Human, rDNA derived) WHO International Standard 1EA
WY-NIBSC-91/550 Epidermal Growth Factor (1-52) (Human, rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-91/554 Insulin-like growth Factor 1 WHO International Standard 1EA
WY-NIBSC-91/612 Influenza anti A/Taiwan/1/86 Serum 1EA
WY-NIBSC-91/624 Recombinant Human Inhibin 1EA
WY-NIBSC-91/626 Activin A, Human, Recombinant. WHO Reference Reagent 1EA
WY-NIBSC-91/656 Interleukin-4 (Mouse, rDNA derived) 1EA
WY-NIBSC-91/658 Granulocyte Macrophage Colony Stimulating Factor (Mouse rDNA derived) 1EA
WY-NIBSC-91/662 Interleukin-3 (Mouse, rDNA derived) 1EA
WY-NIBSC-91/670 Influenza Virus infectious NIB-27 (H1N1) 1EA
WY-NIBSC-91/678 Interleukin-9 (Human,rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-91/682 Stem Cell Factor (Human rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-91/688 Rubella Vaccine (Live) 1st International Reference Reagent 1EA
WY-NIBSC-92/510 Follicle Stimulating Hormone, Human, recombinant. (WHO International Standard) 1EA
WY-NIBSC-92/512 Follicle Stimulating Hormone, urofollitropin Human Urinary WHO International Standard 1EA
WY-NIBSC-92/518 Macrophage Inflammatory Protein-1 alpha (Human, rDNA derived) 1EA
WY-NIBSC-92/520 Rantes (Human, rDNA derived) 1EA
WY-NIBSC-92/530 Influenza Antigen A/Texas/36/91 1EA
WY-NIBSC-92/582 Influenza anti B/Yamagata/16/88 Serum 1EA
WY-NIBSC-92/628 Influenza Antigen B/Yamagata/16/88 1EA
WY-NIBSC-92/632 Influenza anti A/Beijing/352/89 (H3N2) Serum 1EA
WY-NIBSC-92/644 Interleukin-1 Receptor Antagonist (IL-1ra) (Human, rDNA derived) 1EA
WY-NIBSC-92/648 Measles Vaccine (Live) 2nd International Reference Reagent 1EA
WY-NIBSC-92/654 Plasminogen Activator Inhibitor-1 (PAI-1), plasma Human WHO International Standard 1EA
WY-NIBSC-92/658 Papain preparation for use with Anti-D preparation 91/562 1EA
WY-NIBSC-92/734 Influenza Virus infectious A/Beijing/32/92 (H3N2) 1EA
WY-NIBSC-92/738 Influenza Virus infectious A/Shanghai/24/90 1EA
WY-NIBSC-92/788 Interleukin-11 (Human, rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-92/794 Monocyte Chemoattractant Protein-1 (Human,rDNA derived) 1EA
WY-NIBSC-93/500 Influenza Antigen A/Beijing/32/92 1EA
WY-NIBSC-93/516 Influenza Antigen A/Shanghai/24/90 1EA
WY-NIBSC-93/518 Influenza anti A/Beijing/32/92 (H3N2) Serum 1EA
WY-NIBSC-93/522 Influenza anti A/Shanghai/24/90 (H3N2) Serum 1EA
WY-NIBSC-93/556 Nerve Growth Factor (Human, rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-93/560 Insulin-like growth Factor Binding Protein-3 1EA
WY-NIBSC-93/562 Leukaemia Inhibitory Factor (Human, rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-93/564 Oncostatin M (Human, rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-93/566 Interleukin-2 (Mouse, rDNA derived) 1EA
WY-NIBSC-93/568 Influenza Virus infectious A/Beijing/359/89 (H3N2) 1EA
WY-NIBSC-93/574 Bone morphogenetic Protein-2 (Human, rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-93/668 Interleukin-1 beta (Mouse, rDNA derived) 1EA
WY-NIBSC-93/672 Interleukin-1 alpha (Mouse, rDNA derived) 1EA
WY-NIBSC-93/692 Influenza Virus infectious B/Panama/45/90 1EA
WY-NIBSC-93/722 Interleukin-10 (Human rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-93/730 Interleukin-6 (Mouse, rDNA derived) 1EA
WY-NIBSC-93/740 Interleukin-7 (Mouse, rDNA derived) 1EA
WY-NIBSC-93/816 Influenza Virus infectious A/Harbin/15/92 (H3N2) 1EA
WY-NIBSC-94/500 Influenza Antigen B/Panama/45/90 1EA
WY-NIBSC-94/504 Influenza anti A/Shanghai/9/93 Serum 1EA
WY-NIBSC-94/516 Influenza Antigen A/Shangdong/9/93 1EA
WY-NIBSC-94/520 Influenza anti B/Panama/45/90 Serum 1EA
WY-NIBSC-94/532 Pertussis Vaccine (Whole Cell) WHO International Standard 1EA
WY-NIBSC-94/622 Interleukin-13 (Human, rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-94/674 Thyroid Stimulating Hormone, Human recombinant WHO Reference Reagent 1EA
WY-NIBSC-94/684 Ciliary Neurotrophic Factor (Human, rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-94/718 Staphylokinase, rec (STAR) 1EA
WY-NIBSC-94/728 Platelet-derived Growth Factor-BB (Human, rDNA derived) WHO International Standard 1EA
WY-NIBSC-94/730 Tissue Plasminogen Activator (tPA) Antigen in Plasma WHO International Standard 1EA
WY-NIBSC-94/754 Interferon Omega (Human, rDNA derived) WHO International Standard 1EA
WY-NIBSC-94/762 Influenza Virus infectious RESVIR-8 (H3N2) 1EA
WY-NIBSC-94/766 Influenza Virus infectious NIB-34 (H3N2) 1EA
WY-NIBSC-94/784 Interferon alpha (Human, leukocyte derived)WHO International Standard 1EA
WY-NIBSC-94/786 Interferon alpha Concensus Sequence (Human rDNA derived) WHO International Standard 1EA
WY-NIBSC-94/790 MAPREC analysis of Poliovirus type 3 (Sabin). Synthetic DNA 100% 472-C WHO International Standard 1EA
WY-NIBSC-95/510 Influenza Antigen A/Texas/36/91 1EA
WY-NIBSC-95/516 Influenza Antigen A/Johannesburg/33/94 1EA
WY-NIBSC-95/522 Anti-HBc (Anti-hepatitis B core antigen) WHO International Standard 1EA
WY-NIBSC-95/524 Influenza anti A/Johannesburg/33/94 Serum 1EA
WY-NIBSC-95/528 Folate, Whole Blood Haemolysate WHO International Standard 1EA
WY-NIBSC-95/542 MAPREC analysis of Poliovirus type 3 (Sabin) Synthetic DNA 0.9% 472-C WHO International Standard 1EA
WY-NIBSC-95/544 Interleukin-12 (Human, rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-95/554 Interleukin-15 (Human, rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-95/564 Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Non-Glyc) 1EA
WY-NIBSC-95/568 Interferon Alpha n1 (Human lymphoblastoid cell derived) WHO International Standard 1EA
WY-NIBSC-95/572 Interferon alpha-1/8 (Human, rDNA derived) WHO International Standard 1EA
WY-NIBSC-95/574 Interferon Alpha n3 (Human, leukocyte derived) WHO International Standard 1EA
WY-NIBSC-95/580 Interferon alpha-2c (Human, rDNA derived) WHO International Standard 1EA
WY-NIBSC-95/646 Parathyroid Hormone 1-84, human, recombinant (1st International Standard) 1EA
WY-NIBSC-95/650 Interferon alpha-2a (Human, rDNA derived) WHO International Standard 1EA
WY-NIBSC-95/656 Interferon alpha 2b (Human rDNA derived)(3rd International Standard) 1EA
WY-NIBSC-95/668 Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Glyc) 1EA
WY-NIBSC-95/674 Anti-Meningococcal Serogroup A mAb 1EA
WY-NIBSC-95/678 Anti-Meningococcal Serogroup C mAb 1EA
WY-NIBSC-96/528 Soluble Tumour Necrosis Factor Receptor Type 1, (Human, rDNA derived) 1EA
WY-NIBSC-96/532 FMS-like tyrosine kinase 3 ligand (Human, rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-96/534 Brain-derived Neurotrophic Factor (Human, rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-96/538 Insulin-like growth Factor-II (Human rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-96/556 Hepatocyte Growth Factor/Scatter Factor (precursor), (Human rDNA derived) WHO International Standard 1EA
WY-NIBSC-96/564 Hepatocyte Growth Factor/Scatter Factor (Human, rDNA derived) WHO Reference Reagent 1EA
WY-NIBSC-96/572 MAPREC analysis of Poliovirus type 3 (Sabin) Low virus reference 0.7%472-C WHO Reference Reagent 1EA
WY-NIBSC-96/578 MAPREC analysis of Poliovirus type 3 (Sabin) High virus reference 1.1%472-C WHO Reference Reagent 1EA
WY-NIBSC-96/602 Luteinizing Hormone, Human, recombinant WHO International Standard 1EA
WY-NIBSC-96/784 Inhibin B, Human WHO Reference Reagent 1EA
WY-NIBSC-96/836 Influenza Virus infectious RESVIR-9 (H3N2) 1EA
WY-NIBSC-96/850 Influenza Virus infectious NIB-39 (H1N1) 1EA
WY-NIBSC-97/518 Influenza Antigen A/Johannesburg/82/96 1EA
WY-NIBSC-97/538 Anti-Granulocyte Macrophage Colony Stimulating Factor Serum 1EA
WY-NIBSC-97/550 Islet Cell Antibodies WHO Reference Reagent 1EA
WY-NIBSC-97/558 Bordetella pertussis anti 69kD serum (sheep) 1EA
WY-NIBSC-97/562 Blood Coagulation Factors IXa Concentrate, Human, recombinant(1st I.S.) 1EA
WY-NIBSC-97/564 Bordetella pertussis anti FHA serum (sheep) 1EA
WY-NIBSC-97/572 Bordetella pertussis PT anti serum (sheep) 1EA
WY-NIBSC-97/574 Bordetella pertussis anti Fim3 serum (sheep) 1EA
WY-NIBSC-97/584 Influenza Antigen A/Equine/Newmarket/2/93 1EA
WY-NIBSC-97/594 Leptin, Human, Recombinant WHO International Standard 1EA
WY-NIBSC-97/596 Influenza Antigen A/Equine/Newmarket/1/93 1EA
WY-NIBSC-97/600 Interleukin-2 Soluble Receptor (human, rDNA derived) 1EA
WY-NIBSC-97/610 Influenza anti A/equine/Newmarket/1/93 Serum 1EA
WY-NIBSC-97/612 Influenza anti- A/Nanchang/933/95 (H3N2) HA serum 1EA
WY-NIBSC-97/614 Influenza anti A/Equine/Newmarket/2/93 (H3N8) HA Serum (SH-376) 1EA
WY-NIBSC-97/626 Leptin, Mouse, Recombinant WHO International Standard 1EA
WY-NIBSC-97/642 Bordetella pertussis anti serum (mouse) 1RR 1EA
WY-NIBSC-97/646 Anti-Hepatitis A Immunoglobulin, Human (W1041) WHO International Standard 1EA
WY-NIBSC-97/648 Anti-Measles serum (3rd International Standard) 1EA
WY-NIBSC-97/692 Influenza Virus infectious IVR-108 (H3N2) 1EA
WY-NIBSC-97/714 Prolactin, Human, recombinant. WHO Reference Reagent 1EA
WY-NIBSC-97/722 Influenza Virus infectious A/duck/Sing-Q/119/97 (H5N3) 1EA
WY-NIBSC-97/748 Influenza Antigen B/Harbin/7/94 1EA
WY-NIBSC-97/756 MAPREC analysis of Poliovirus type 2 (Sabin), low virus reference 0.65%481-G. WHO Reference Reagent 1EA
WY-NIBSC-97/758 MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA 0.67%481-G WHO International Standard 1EA
WY-NIBSC-97/760 Influenza Antigen A/Beijing/262/95 1EA
WY-NIBSC-98/524 MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA, 100%481-G WHO International Standard 1EA
WY-NIBSC-98/544 Influenza Virus infectious RESVIR-13 (H3N2) 1EA
WY-NIBSC-98/572 Diphtheria and Tetanus Antitoxin, Guinea Pig Serum 1EA
WY-NIBSC-98/574 Somatropin WHO International Standard 1EA
WY-NIBSC-98/580 Prolactin Human, recombinant, glycosylated WHO Reference Reagent 1EA
WY-NIBSC-98/582 Prolactin, Human, recombinant, non-glycosylated WHO Reference Reagent 1EA
WY-NIBSC-98/586 Calcitonin, Salmon. WHO International Standard 1EA
WY-NIBSC-98/596 MAPREC analysis of Poliovirus type 2 (Sabin), high virus reference 1.21% 481-G. WHO Reference Reagent 1EA
WY-NIBSC-98/600 Influenza Virus infectious NIB-40 (H5N3) 1EA
WY-NIBSC-98/604 Influenza anti B/Harbin/7/94/HA Serum 1EA
WY-NIBSC-98/610 Influenza Virus infectious ARIV-1 (H5N3) 1EA
WY-NIBSC-98/666 Influenza anti A/Hong Kong/489/97 (H5N1) Serum (sheep) 1EA
WY-NIBSC-98/686 Negative Control Guinea Pig Serum (Diphtheria and Tetanus Serology) 1EA
WY-NIBSC-98/708 Haemiglobincyanide WHO International Standard 1EA
WY-NIBSC-98/714 Tissue Plasminogen Activator, Human, Recombinant WHO International Standard 1EA
WY-NIBSC-98/718 Neurotrophin 3 1EA
WY-NIBSC-98/762 Influenza Virus infectious Resvir-14 (H3N2) 1EA
WY-NIBSC-98/772 Influenza anti A/Beijing/262/95 Serum 1EA
WY-NIBSC-98/774 Influenza Antigen B/Shangdong/7/97 1EA
WY-NIBSC-99/506 Anti-PT S1 subunit Monoclonal Antibody (1B7) 1EA
WY-NIBSC-99/508 Anti-PT S1 subunit Monoclonal Antibody (1D7) 1EA
WY-NIBSC-99/510 Anti-PT S1 subunit Monoclonal Antibody (3F11) 1EA
WY-NIBSC-99/512 Anti-PT S1 subunit Monoclonal Antibody (10D6) 1EA
WY-NIBSC-99/516 Anti-PT S1 subunit Monoclonal Antibody (E1E) 1EA
WY-NIBSC-99/518 Anti-PT S1 subunit Monoclonal Antibody (E2E) 1EA
WY-NIBSC-99/520 Anti-PT S1 subunit Monoclonal Antibody (3F10) 1EA
WY-NIBSC-99/522 Anti-PT S1 subunit Monoclonal Antibody (11D9) 1EA
WY-NIBSC-99/524 Anti-PT S1 subunit Monoclonal Antibody (4D10) 1EA
WY-NIBSC-99/526 Anti-PT S23 subunit Monoclonal Antibody (11E6) 1EA
WY-NIBSC-99/528 Anti-PT S23 subunit Monoclonal Antibody (10C9) 1EA
WY-NIBSC-99/530 Anti-PT S23 subunit Monoclonal Antibody (10B5) 1EA
WY-NIBSC-99/532 Anti-PT S23 subunit Monoclonal Antibody (G9A) 1EA
WY-NIBSC-99/534 Anti-PT S23 subunit Monoclonal Antibody (3F6) 1EA
WY-NIBSC-99/536 Anti-PT S2 subunit Monoclonal Antibody (3A12) 1EA
WY-NIBSC-99/538 Anti-PT S2 subunit Monoclonal Antibody (2H3) 1EA
WY-NIBSC-99/540 Anti-PT S2 subunit Monoclonal Antibody (9G8) 1EA
WY-NIBSC-99/542 Anti-PT S3 subunit Monoclonal Antibody (7E10) 1EA
WY-NIBSC-99/544 Anti-PT S3 subunit Monoclonal Antibody (7G11) 1EA
WY-NIBSC-99/546 Anti-PT S3 subunit Monoclonal Antibody (4G5) 1EA
WY-NIBSC-99/548 Anti-PT S3 subunit Monoclonal Antibody (2E12) 1EA
WY-NIBSC-99/550 Anti-PT S3 subunit Monoclonal Antibody (6F8) 1EA
WY-NIBSC-99/552 Anti-PT S3 subunit Monoclonal Antibody (10B8) 1EA
WY-NIBSC-99/554 Anti-PT S4 subunit Monoclonal Antibody (7F2) 1EA
WY-NIBSC-99/556 Anti-PT S4 subunit Monoclonal Antibody (6B3) 1EA
WY-NIBSC-99/558 Anti-PT S4 subunit Monoclonal Antibody (6G8) 1EA
WY-NIBSC-99/560 Anti-PT S4 subunit Monoclonal Antibody (9F3) 1EA
WY-NIBSC-99/562 Anti-PT S4 subunit Monoclonal Antibody (1H2) 1EA
WY-NIBSC-99/564 Anti-PT S4 subunit Monoclonal Antibody (9C6) 1EA
WY-NIBSC-99/566 Anti-PT S4 subunit Monoclonal Antibody (6D6) 1EA
WY-NIBSC-99/568 Anti-PT S5 subunit Monoclonal Antibody (7E3) 1EA
WY-NIBSC-99/570 Anti Filamentous Haemagglutinin Monoclonal Antibody (1C6) 1EA
WY-NIBSC-99/572 Anti-Filamentous Haemagglutinin Monoclonal Antibody (2E9) 1EA
WY-NIBSC-99/574 Anti Filamentous Haemagglutinin Monoclonal Antibody (12G10) 1EA
WY-NIBSC-99/586 Influenza Antigen B/Yamanashi/166/98 1EA
WY-NIBSC-99/614 Influenza Antigen A/Sydney/5/97 1EA
WY-NIBSC-99/616 Yellow Fever Vaccine. WHO International Standard 1EA
WY-NIBSC-99/624 Influenza Antigen A/Sydney/5/97 1EA
WY-NIBSC-99/642 Chorionic Gonadotrophin, nicked, human. WHO Reference Reagent 1EA
WY-NIBSC-99/650 Chorionic Gonadotrophin, beta subunit, human. WHO Reference Reagent 1EA
WY-NIBSC-99/666 Anti-HPA-5b (Minimum Potency) WHO Reference Reagent 1EA
WY-NIBSC-99/674 HIV-2 (antibody) Monitor Sample 1EA
WY-NIBSC-99/688 Chorionic Gonadatrophin, intact, Human. WHO Reference Reagent 1EA
WY-NIBSC-99/692 Chorionic Gonadotrophin, nicked beta subunit, Human WHO Reference Reagent 1EA
WY-NIBSC-99/706 Anti-Meningococcal human reference serum CDC1992 1EA
WY-NIBSC-99/708 Chorionic Gonadatrophin, beta core fragment, Human WHO Reference Reagent 1EA
WY-NIBSC-99/710 Anti-HIV 1 (1 in 5 BWS) 1EA
WY-NIBSC-99/720 Chorionic Gonadotrophin, alpha subunit, Human (purified) 1EA
WY-NIBSC-99/750 British Working Standard for Anti-HIV 1 1EA
WY-NIBSC-99/824 Influenza Virus infectious RESVIR 16 (H3N2) 1EA
WY-NIBSC-99/828 Influenza Antigen B/Yamanashi/166/98 1EA
WY-NIBSC-99/836 Anti-D Minimum Potency Standard for blood grouping reagents WHO International Standard 1EA
WY-NIBSC-AFP Alpha-Foetoprotein. WHO International Standard 1EA
WY-NIBSC-BUSB Botulinum Antitoxin Equine Type B. WHO International Standard 1EA
WY-NIBSC-CDS Anti-Canine Distemper Serum. WHO International Standard 1EA
WY-NIBSC-CHAN Cholera Antitoxin, Goat. WHO International Standard 1EA
WY-NIBSC-CHS Anti-Canine Hepatitis Serum 1EA
WY-NIBSC-COT Clostridium novyi (alpha) Toxoid. WHO Reference Reagent 1EA
WY-NIBSC-CWBETATD Clostridium Welchii (Perfringens)(Beta) Toxoid CwBT WHO Reference Reagent 1EA
WY-NIBSC-CWEPSILTD Clostridium Welchii (Perfringens) (Epsilon) toxoid 1EA
WY-NIBSC-DIM9 Diphtheria toxoid monoclonal antibody, clone Dim9 1EA
WY-NIBSC-DT05 Diphtheria toxoid monoclonal antibody, clone DT05 1EA
WY-NIBSC-DY Anti-Dysentery (shiga) serum, Equine. WHO International Standard 1EA
WY-NIBSC-FHADETOX/6 Filamentous Haemagglutinin monoclonal antibody, clone FHADETOX/6 1EA
WY-NIBSC-G10F8C3 Fimbrae monoclonal antibody, clone G10F8C3 1EA
WY-NIBSC-HBOHA Lyophilised HBO-HA Antigen for ELISA, Lot 17 1EA
WY-NIBSC-JNIH-11 Bordetella pertussis anti FHA serum (mouse) 1EA
WY-NIBSC-JNIH-12 Bordetella pertussis PT( LPF) anti serum, (mouse) 1EA
WY-NIBSC-JNIH-3 Acellular Pertussis Vaccine - 1st IS 1EA
WY-NIBSC-JNIH-4 Bordetella pertussis filamentous haemagglutinin (FHA) 1EA
WY-NIBSC-MGDS Anti-Mycoplasma gallisepticum Serum. WHO Reference Reagent 1EA
WY-NIBSC-NDS Anti-Newcastle Disease Serum. WHO International Standard 1EA
WY-NIBSC-NVIA Newcastle Disease Vaccine (Inactivated) WHO International Standard 1EA
WY-NIBSC-OE Gas Gangrene Antitoxin (Cl. novyi), Equine WHO International Standard 1EA
WY-NIBSC-PE Gas Gangrene Antitoxin (Cl. Perfringens alpha antitoxin) Equine WHO International Standard 1EA
WY-NIBSC-PPDBOV Purified Protein Derivative (PPD) of Mycobacterium bovis Tuberculin (WHO 1st International Standard) 1EA
WY-NIBSC-PPDT Purified Protein Derivative (PPD) of M. Tuberculosis Tuberculin WHO International Standard 1EA
WY-NIBSC-PS21C2.2.1 Pertussis toxoid monoclonal antibody, clone PS21C2.2.1 1EA
WY-NIBSC-QF Anti-Q Fever Serum, Bovine WHO International Standard 1EA
WY-NIBSC-RBT/16 Thromboplastin, Rabbit, Plain 5th International Standard 2016 1EA
WY-NIBSC-RTF/16 Thromboplastin, Human, Recombinant, Plain 5th International Standard 2016 1EA
WY-NIBSC-RUBI-1-94 Anti-rubella Immunoglobulin, Human WHO International Standard 1EA
WY-NIBSC-SES Swine Erysipelas Serum (anti-N) WHO Reference Reagent 1EA
WY-NIBSC-SFS Anti-Swine Fever Serum WHO International Standard 1EA
WY-NIBSC-SMV Smallpox Vaccine WHO International Standard 1EA
WY-NIBSC-SPDS-S2 Anti-Salmonella Pullorum Serum (Std. Form S) WHO International Standard 1EA
WY-NIBSC-SPDS-V Anti-Salmonella Pullorum Serum (Variant Form V) WHO International Standard 1EA
WY-NIBSC-SPLS Anti-Staphylococcal P-V Leucocidin serum, Equine WHO Reference Reagent 1EA
WY-NIBSC-STA Staphylococcus Alpha Antitoxin, Equine WHO International Standard 1EA
WY-NIBSC-STT Diphtheria (Schick) Test Toxin WHO International Standard 1EA
WY-NIBSC-TILI Anti-tick borne encephalitis serum (Louping Ill) WHO International Standard 1EA
WY-NIBSC-TISA Anti-tick borne encephalitis serum (Sophyn & Absettarov) WHO International Standard 1EA
WY-NIBSC-TT010 Tetanus toxoid monoclonal antibody, clone TT010 1EA
WY-NIBSC-TYVK Typhoid Vaccine (acetone-inactivated) WHO International Standard 1EA
WY-NIBSC-TYVL Typhoid Vaccine (heat-phenol-inactivated) WHO International Standard 1EA
WY-NIBSC-VI Gas Gangrene Antitoxin (Cl. Septicum), Equine WHO International Standard 1EA
WY-NIBSC-W1004 Anti-C complete blood typing serum,human WHO International Standard 1EA
WY-NIBSC-W1005 Anti-E complete blood typing serum, human WHO International Standard 1EA
WY-NIBSC-W1007 Anti-c Incomplete blood typing serum, human WHO International Standard 1EA
WY-NIBSC-W1044 Anti-Varicella zoster immunoglobulin WHO International Standard 1EA
WY-NIBSC-W1062 Anti smooth muscle(anti actin) autoantibody. WHO Reference Reagent 1EA
WY-NIBSC-W1063 Anti nuclear ribonucleoprotein(nRNP) autoantibody WHO Reference Reagent 1EA
WY-NIBSC-W1064 Anti-Nuclear factor serum,homogenous(66/233) 1EA
WY-NIBSC-YF Anti-Yellow Fever Serum, monkey WHO Reference Reagent 1EA
WY-NIBSC-04/122 Anti-Meningococcal Serosubtype P1.12 mAb 1EA
WY-NIBSC-100978 VeroE6/TMPRSS2 1EA
WY-NIBSC-101044 SARS-CoV-2 Omicron (lineage B.1.1.529) 1EA
WY-NIBSC-12/300 Negative Control IVIG (for use with IVIG and Anti-D) 1EA
WY-NIBSC-12/306 Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP)(2nd International Standard) 1EA
WY-NIBSC-13/256 Influenza virus infectious. NYMC x-233 1EA
WY-NIBSC-15/298 Influenza Virus Infectious B/Brisbane/46/2015 1EA
WY-NIBSC-16/B707 QCREBVNEGQC1 1EA
WY-NIBSC-17/160 Sabin Inactivated Polio Vaccine (sIPV) (WHO 1st international Standard) 1EA
WY-NIBSC-18/206 West Nile Virus - International Standard 1EA
WY-NIBSC-22/240 Anti-pneumococcal serotype 6B monoclonal antibody (clone 14-102GA3 ID10 1B10) 1EA
WY-NIBSC-73/601 Carcinoembryonic Antigen (CEA), Human (1st International Reference Preparation) 1EA
WY-NIBSC-98/778 Influenza Virus infectious A/Sichuan/346/98 (H3N2) 1EA
WY-NIBSC-99/514 Anti-PT S1 subunit Monoclonal Antibody (8G4) 1EA

联系方式
手机:15317051735
Q Q:
二维码扫描访问